Malignant neoplasm of prostate, including Hilmo

C3_PROSTATE_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only males	226754
2. Check conditions None	226754
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C61 Hospital discharge: ICD-9 — 185 Hospital discharge: ICD-8 — 185 Cause of death: ICD-10 — C61 Cause of death: ICD-9 — 185 Cause of death: ICD-8 — 185 KELA reimbursements: KELA codes — 116 Cancer registry: Topography ICD-O-3 — C61 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 4 out of 7 registries used, show all original rules.	22097
4. Check minimum number of events None	22097
5. Include endpoints None	22097
6. Filter based on genotype QC (FinnGen only)	21482

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_PROSTATE_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C61
HD_ICD_9	185
HD_ICD_8	185
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C61
COD_ICD_9	185
COD_ICD_8	185
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	116
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C61
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of prostate, including Hilmo based on the number of shared cases.

Similar with more cases:

Malignant neoplasm, wide definition for exclusion

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	21482	-	21482
Unadjusted period prevalence (%)	9.84	-	9.84
Median age at first event (years)	69.43	-	69.43

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14819: Matched controls
88064

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

78.1

317.3

271

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

395.0

317.0

389

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

1097.0

310.1

372

B01AB05

ATC

enoxaparin; parenteral

2.1

310.0

4496

15136

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

11.9

307.7

823

434

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

307.7

1193

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

307.7

447

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

14811.9

307.7

2141

KE1CG

NOMESCO Finland

Extensive MRI of prostate

27.4

307.7

522

117

H02AB02

ATC

dexamethasone; systemic

28.0

307.7

1568

370

L02BB03

ATC

bicalutamide; oral

16384.0

307.7

2829

A04AA02

ATC

granisetron; systemic, transdermal

300.6

307.7

722

XKD00

NOMESCO Finland

Uroflowmetry

6.9

307.7

8017

12904

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

307.7

652

116

Kela drug reimbursment

Prostate cancer

+∞

307.7

7588

XX3DW

NOMESCO Finland

Time consuming IT work

14.9

307.7

3526

1805

N40

ICD-10 Finland

Hyperplasia of prostate

2.0

307.7

7225

28246

3054, ,

Kela drug reimbursment

+∞

307.7

483

N02AA05

ATC

oxycodone; systemic

2.7

307.7

2689

6745

WF004

NOMESCO Finland

Palliative radiotherapy

1363.2

307.7

457

G04CA02

ATC

tamsulosin; oral

2.1

307.7

7636

29746

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

307.7

395

KE1DG

NOMESCO Finland

Very extensive MRI of prostate

19.9

307.7

772

242

L02BX03

ATC

abiraterone; oral

+∞

307.7

629

A03FA01

ATC

metoclopramide; systemic, rectal

4.9

307.7

2405

3327

NK6AN

NOMESCO Finland

Total body bone isotope imaging

259.8

307.7

1669

KDE20

NOMESCO Finland

Removal of foreign body from urethra

20.7

307.7

549

163

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

735

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

307.7

3129

TKE00

NOMESCO Finland

Needle biopsy of prostate

14.5

307.7

2942

1484

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

307.7

425

WZC30

NOMESCO Finland

Teaching

3.1

307.7

2675

5891

M05BX04

ATC

denosumab; parenteral

13.1

307.7

1087

530

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

126.0

307.7

1675

A04AA01

ATC

ondansetron; systemic, rectal

9.7

307.7

784

505

L03AA13

ATC

pegfilgrastim; parenteral

573.8

307.7

558

L02AE04

ATC

triptorelin; parenteral

3125.4

307.7

995

WZC00

NOMESCO Finland

Treatment plan or consultation

4.0

307.7

6312

13772

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

307.7

504

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

213.2

307.7

814

J01EA01

ATC

trimethoprim; systemic

4.0

307.7

3305

5849

ZX080

NOMESCO Finland

Image guided radiotherapy

1043.5

307.7

497

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

910

JN4AD

NOMESCO Finland

Body CT examination

5.8

307.7

2232

2591

Y77

ICPC

Malignant neoplasm prostate

1685.6

307.7

3306

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

17.0

307.7

1971

789

UKC02

NOMESCO Finland

Cystoscopy

3.2

307.7

4416

10320

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

307.7

902

1523, ,

Kela drug reimbursment

+∞

307.7

485

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

9.6

307.7

830

542

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

779

WF003

NOMESCO Finland

Adjuvant radiotherapy

484.6

307.7

773

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

233.8

307.7

888

N39.3

ICD-10 Finland

Stress incontinence

19.9

307.7

458

141

WF049

NOMESCO Finland

Radiotherapy of metastasis

1546.8

307.7

998

L02BB04

ATC

enzalutamide; oral

+∞

307.7

875

L02AE02

ATC

leuprorelin; implant, parenteral

4503599627370496.0

307.7

4996

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

182.6

307.7

418

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

307.7

3893

11832

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

5.8

307.7

6440

10359

G04BE01

ATC

alprostadil; parenteral, urethral

7.9

307.7

1051

839

L02AE03

ATC

goserelin; implant

3663.0

307.7

598

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

1474.9

307.7

1177

L02BX02

ATC

degarelix; parenteral

+∞

307.7

1126

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

57.5

307.7

788

ZX112

NOMESCO Finland

Subcutaneous

16.7

307.7

515

189

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

19.7

307.7

574

180

XJH00

NOMESCO Finland

Transanal ultrasonography

5.4

307.7

2905

3820

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

6042.4

307.7

958

ZXC96

NOMESCO Finland

Robot assisted procedure

130.3

307.7

1995

105

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

46.2

307.7

6816

1593

K62.7

ICD-10 Finland

Radiation proctitis

2461.4

307.7

409

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

15.2

307.7

1049

439

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

33.4

307.7

400

JN4BD

NOMESCO Finland

Extensive body CT

7.0

307.7

2267

2203

ZX070

NOMESCO Finland

Intensity modified radiotherapy

+∞

307.7

702

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

1406

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

307.7

1081

R31

ICD-10 Finland

Unspecified haematuria

2.6

307.7

2619

6663

TKE10

NOMESCO Finland

Puncture of prostate

210.1

307.7

512

C61

ICD-10 Finland

Malignant neoplasm of prostate

82457.5

307.7

14468

G04BE03

ATC

sildenafil; oral

37.6

307.7

1130

193

G03HA01

ATC

cyproterone; systemic

96.3

307.7

486

KC1GB

NOMESCO Finland

Cystography with X-ray

145.8

307.7

768

KCD02

NOMESCO Finland

Transurethral resection of bladder

24.9

307.7

577

143

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

376.2

307.7

1533

A79

ICPC

Malignancy NOS

133.0

307.7

307

WF002

NOMESCO Finland

Radical radiotherapy

675.7

307.7

3929

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

21.5

307.7

425

121

ZX090

NOMESCO Finland

Other technic of radiotherapy

446.4

307.7

715

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

13284

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.8

307.7

4998

10496

KE1BG

NOMESCO Finland

MRI of prostate

29.4

307.7

753

160

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

3770.5

307.7

1182

KEB00

NOMESCO Finland

Biopsy of prostate

18.3

307.7

826

283

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

3.9

307.7

4044

7683

J01MA02

ATC

ciprofloxacin; systemic

2.3

307.7

7057

24854

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

19.0

307.7

4891

2230

Z51.5

ICD-10 Finland

Palliative care

6.3

307.7

1317

1341

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.8

307.7

1109

1446

JN4CD

NOMESCO Finland

Very extensive body CT

6.8

303.2

615

558

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

365.8

293.3

361

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

291.8

345

ZX050

NOMESCO Finland

Stereotactic radiotherapy

68.4

287.6

249

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

354.4

284.0

350

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

11.6

277.2

390

204

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

1949.9

274.1

327

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

37.6

269.5

255

Z51.0

ICD-10 Finland

Radiotherapy session

999.3

267.7

322

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

5.4

267.0

671

771

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

266.3

315

KFC10

NOMESCO Finland

Bilateral orchiectomy

222.5

263.3

331

ZXC20

NOMESCO Finland

Use of chemical agents

9.6

259.0

407

258

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

64.3

256.9

224

L03AA02

ATC

filgrastim; parenteral

33.8

254.4

246

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.0

248.5

677

841

Y06

ICPC

Prostate symptom/complaint

3.4

243.3

1104

2056

G04BD12

ATC

mirabegron; oral

2.5

243.0

2012

5268

KE1DR

NOMESCO Finland

Prostate metabolic PET with CT

1671.7

235.9

282

G04BE30

ATC

drugs used in erectile dysfunction - combinations

435.8

235.2

288

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

851.4

231.3

279

L01BC06

ATC

capecitabine; oral

+∞

228.1

270

OAB42

NOMESCO Finland

Guidance related to known health problem

26.1

222.7

229

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

7.9

222.4

399

308

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

33.8

220.3

213

WX402

NOMESCO Finland

General anaesthesia

2.1

218.9

2686

8315

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

217.1

257

KED22

NOMESCO Finland

Transurethral resection of prostate

2.4

216.0

1882

5030

XX1AD

NOMESCO Finland

Other CT-examination

84.7

215.9

183

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

1511.7

213.9

256

1850A

ICD-9 Finland

Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]

+∞

208.6

247

B01AB10

ATC

tinzaparin; parenteral

2.9

208.6

1241

2724

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

206.0

6036

24868

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

47.1

197.9

180

R33

ICD-10 Finland

Retention of urine

2.2

195.3

2119

6216

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

195.1

231

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

1358.5

192.8

231

WVA30, ,

SPAT

3.0

192.3

1027

2113

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

164.2

190.7

244

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

183.2

217

N02BE01

ATC

paracetamol; systemic, rectal

1.9

182.6

12198

62405

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.6

179.5

431

471

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

179.4

1439

3682

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

10.7

178.3

262

148

TQW40

NOMESCO Finland

Remowal of suture of skin

2.8

178.2

1069

2351

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

177.3

210

TKC52

NOMESCO Finland

Patient education concerning pelvic floor contraction exercises

51.7

172.8

155

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

46.5

170.1

155

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

417.3

169.6

208

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

167.1

198

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

164.6

195

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

5.8

158.9

368

387

U04

ICPC

Incontinence urine

3.2

158.6

748

1421

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.1

158.0

529

784

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

294.3

157.9

196

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

157.8

187

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

58.7

155.3

137

G04BD08

ATC

solifenacin; oral

2.7

154.8

1035

2410

G04BE09

ATC

vardenafil; oral

77.9

152.1

130

L57.0

ICD-10 Finland

Actinic keratosis

2.4

151.4

1271

3312

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

53.6

150.1

134

KCC10

NOMESCO Finland

Cystoprostatectomy

368.5

149.4

184

L01XX11

ATC

estramustine; systemic

+∞

149.3

177

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

148.5

176

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

364.4

147.8

182

N02AX02

ATC

tramadol; systemic, rectal

1.6

147.7

6260

27661

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

32.5

144.7

141

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

144.3

171

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

27.2

142.7

145

KD1GB

NOMESCO Finland

Uretrocystogpaphy with X-ray

19.5

141.7

159

A06AH03

ATC

naloxegol; oral

11.5

141.3

199

104

KDW96

NOMESCO Finland

Other operations on urethra

49.9

138.6

125

L02BB01

ATC

flutamide; oral

+∞

135.8

161

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

131.3

1971

6465

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.5

130.6

549

964

JN4LR

NOMESCO Finland

Extensive PET-CT of receptors in whole body

+∞

129.9

154

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.4

128.6

1085

2826

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

941.2

127.8

154

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

123.3

4520

19071

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

123.1

146

WB221

NOMESCO Finland

Demanding neoadjuvant hormone therapy of malignancy

+∞

123.1

146

WF099

NOMESCO Finland

Other radiotherapy

25.4

122.7

127

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

9.2

122.7

197

129

PJA12

NOMESCO Finland

Sentinel node biopsy

446.7

121.7

149

J01MA12

ATC

levofloxacin; systemic

1.7

119.6

2772

10380

WW500

NOMESCO Finland

Blood transfusion

3.7

119.5

456

747

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.7

119.0

341

442

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

104.8

118.7

157

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

222.7

118.6

149

TKC22

NOMESCO Finland

Catheterisation instruction

3.2

118.5

577

1116

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

43.5

118.3

109

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

52.4

117.2

105

A04AA55

ATC

palonosetron, combinations; systemic

+∞

117.2

139

3031

Kela drug reimbursment

Apalutamidi

+∞

117.2

139

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

9.6

116.9

183

115

1528, ,

Kela drug reimbursment

+∞

116.4

138

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.7

114.9

725

1631

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

+∞

114.7

136

L02BB05

ATC

apalutamide; oral

+∞

114.7

136

XKG00

NOMESCO Finland

Artificial induction of erection

18.5

113.9

130

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

807.1

110.9

134

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

407.3

110.8

136

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.8

109.9

645

1394

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.1

109.8

366

540

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.7

108.8

723

1672

G04CA01

ATC

alfuzosin; oral

1.6

108.3

3515

14318

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

107.1

127

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

105.4

125

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

105.4

125

R86.1

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of hormones

9.7

104.7

162

100

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

21.8

104.6

113

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

103.7

123

Z3231

NOMESCO Finland

Registered nurse

1.6

103.6

3603

14896

TJF80

NOMESCO Finland

Ostomy education

11.3

100.7

143

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

99.5

118

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

37.5

99.3

ZX136

NOMESCO Finland

Intravesicalis

14.4

99.1

125

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

6.6

97.6

200

183

U77

ICPC

Malignant neopl urinary tract other

+∞

96.9

115

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

355.8

96.6

119

S77

ICPC

Malignant neoplasm of skin

24.2

96.3

101

7512

FHL

Orchidectomy (bilateral)

+∞

96.1

114

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

182.1

95.3

121

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

95.3

113

N30.4

ICD-10 Finland

Irradiation cystitis

+∞

94.4

112

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

4.0

94.0

324

491

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.7

93.7

606

1380

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

92.7

110

XX7FT

NOMESCO Finland

Radioyttrium therapy with connected antibody

664.2

91.6

111

UJF32

NOMESCO Finland

Coloscopy

1.6

91.2

3261

13503

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

91.0

108

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

91.0

108

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.2

90.4

294

425

KDG43

NOMESCO Finland

Transobturatorial sling urethrocystopexy

172.8

90.3

115

R86.9

ICD-10 Finland

Abnormal findings in specimens from male genital organs, unspecified abnormal finding

8.0

89.1

157

118

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

88.8

1932

7049

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

88.1

976

2843

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

87.9

6376

30406

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

5.8

86.9

200

209

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

13.7

86.8

112

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

4.2

85.7

275

393

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

111.8

85.3

112

ZZR00

NOMESCO Finland

Flap of skin

5.7

85.3

199

211

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

313.5

84.9

105

XKD03

NOMESCO Finland

Urethral pressure profilometry

4.5

84.2

247

327

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

610.0

84.0

102

XX2RW, ,

NOMESCO Finland

7.4

83.1

155

126

XX1XQ

NOMESCO Finland

Other SPECT-CT

+∞

81.7

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

33.7

81.7

G04BE08

ATC

tadalafil; oral

17.6

80.8

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

80.4

1383

4698

2BX02, ,

NOMESCO Finland

+∞

80.1

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

152.7

79.5

102

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

20.2

79.5

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

90.6

79.2

106

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

151.2

78.7

101

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

78.6

504

1142

A04AD12

ATC

aprepitant; systemic

+∞

78.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

78.4

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

12.4

77.1

104

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

76.8

1168

3811

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

76.8

1488

5238

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

283.4

76.5

N99.1

ICD-10 Finland

Postprocedural urethral stricture

5.4

76.1

186

207

8000/3-C61.9

ICD-O-3

Neoplasm, malignant of prostate gland

+∞

75.0

B02AA02

ATC

tranexamic acid; systemic

2.3

74.7

695

1881

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

21.0

74.1

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

72.7

1514

5436

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

72.5

DAB10

NOMESCO Finland

Partial excision of auricle

34.3

71.6

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

71.2

4432

20338

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

70.8

1025

3286

KA3EB

NOMESCO Finland

Antegrade pyelography

8.8

70.5

116

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

38.8

69.1

1CD02, ,

NOMESCO Finland

+∞

69.1

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

4.3

67.7

210

292

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

67.4

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

67.4

8221

42036

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

66.6

ZXC50

NOMESCO Finland

Cryotherapy

3.2

66.4

310

583

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

65.7

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

477.5

65.6

ZX112, ,

SPAT

15.4

65.4

KDK10

NOMESCO Finland

Implantation of artificial urinary sphincter around bulbar urethra

125.5

64.7

ZX022

NOMESCO Finland

LDR radiotherapy within tissue

125.5

64.7

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

101.6

64.3

JGA28

NOMESCO Finland

Endoscopic contact coagulation in rectum

27.7

64.3

HB000

NOMESCO Finland

Profylactic radiotherapy of mammary gland

+∞

64.0

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

64.0

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.1

63.8

705

2047

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

22.5

63.6

WVA20

NOMESCO Finland

Medicine administration

2.8

63.4

367

786

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.3

63.4

277

499

WX320

NOMESCO Finland

Spinalanesthesy

1.5

63.2

3035

13219

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

63.2

U06

ICPC

Haematuria

2.6

63.1

429

1002

U76

ICPC

Malignant neoplasm of bladder

459.5

63.0

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

159.7

62.6

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

12.5

62.6

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

62.1

2747

11766

N30.0

ICD-10 Finland

Acute cystitis

1.9

61.8

979

3229

D75

ICPC

Malignant neoplasm colon/rectum

28.5

61.7

D70.82

ICD-10 Finland

Drug-induced neutropenia

8.0

61.5

108

JN6AD

NOMESCO Finland

CT of torso and neck

5.6

61.2

143

152

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

61.2

1507

5650

S18

ICPC

Laceration/cut

1.4

60.5

5770

28213

R4110

NOMESCO Finland

Physiotherapy

1.4

60.3

3193

14148

N35.9

ICD-10 Finland

Urethral stricture, unspecified

3.0

60.1

311

624

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

59.9

514

1342

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.8

59.6

214

335

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

55.8

59.4

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

59.0

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

57.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

56.4

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.4

55.9

117

110

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

65.7

55.7

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.7

55.6

128

134

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

88.4

55.3

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

55.0

433

1086

C20

ICD-10 Finland

Malignant neoplasm of rectum

205.0

54.9

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

205.0

54.9

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

54.8

WF001

NOMESCO Finland

Preoperative radiotherapy

399.4

54.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

54.4

1660

6547

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

53.9

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

11.3

53.8

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.7

53.8

152

195

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

53.6

1770

7108

SPAT1153

SPAT

Removal of sutures

1.4

53.5

3824

17783

ZXC15

NOMESCO Finland

Use of photodynamic technique

5.0

53.2

140

168

C90.0

ICD-10 Finland

Multiple myeloma

199.0

53.2

ZXE00

NOMESCO Finland

One hour or less

1.4

52.9

4328

20556

JFF23

NOMESCO Finland

Transversostomy

6.8

52.8

104

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

55.3

52.3

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.8

52.2

309

670

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

381.4

52.2

DAB00

NOMESCO Finland

Excision of lesion of auricle

5.8

51.4

117

121

J01MA01

ATC

ofloxacin; systemic

1.7

51.4

1203

4441

YX9AW, ,

NOMESCO Finland

+∞

51.4

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

51.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

375.4

51.3

ZX120

NOMESCO Finland

Intravenous

1.8

51.3

921

3155

XX7LT

NOMESCO Finland

Lutetium-177-PSMA treatment

+∞

50.5

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

49.7

D07.5

ICD-10 Finland

Carcinoma in situ: Prostate

127.3

49.4

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

12.1

49.1

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.6

49.0

330

767

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

48.8

A02BC02

ATC

pantoprazole; systemic

1.3

48.4

8302

43570

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

48.0

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

6.8

47.8

Z2221

NOMESCO Finland

Medical doctor

1.4

47.7

2816

12647

NK6SN

NOMESCO Finland

Bone SPECT

179.9

47.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

47.2

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

176.8

46.6

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

46.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

339.4

46.3

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

46.2

578

1756

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.2

46.2

209

386

WZC15, ,

NOMESCO Finland

13.3

46.0

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

3.8

45.8

166

262

R50.9

ICD-10 Finland

Fever, unspecified

1.5

45.6

1651

6749

L02BB06

ATC

darolutamide; oral

+∞

45.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

45.5

Y78

ICPC

Malign neopl male genital other

333.4

45.5

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

170.6

44.9

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

44.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

44.6

UKD02

NOMESCO Finland

Urethroscopy

4.9

44.6

119

145

KDV10

NOMESCO Finland

Internal urethrotomy

2.7

44.5

270

594

JG1CG

NOMESCO Finland

Extensive MRI of rectum

17.2

44.4

KAC10

NOMESCO Finland

Total nephrectomy with capsule

13.1

43.4

JG1BG

NOMESCO Finland

MRI of rectum

12.1

43.3

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

11.4

43.3

J01CA08

ATC

pivmecillinam; oral

1.7

43.2

826

2879

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

43.2

343

864

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

4.8

43.1

117

145

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

315.4

43.0

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

42.9

XX7AT

NOMESCO Finland

Radiation therapy with Radium-223

+∞

42.9

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

111.3

42.9

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

161.4

42.4

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

309.4

42.1

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

42.1

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

42.1

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

22.3

42.0

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

13.1

41.9

JGA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in rectum

25.6

41.7

KCW96

NOMESCO Finland

Other operations on bladder

5.5

41.4

106

L02AE01

ATC

buserelin; implant, nasal, parenteral

+∞

41.3

A06AD11

ATC

lactulose; oral

1.5

41.1

1843

7854

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

40.8

505

1529

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

66.8

40.7

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.9

40.6

222

461

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

40.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

40.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

40.3

1153

4466

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.8

40.1

239

521

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

65.6

39.9

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

39.6

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

39.6

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

39.6

KE1AE

NOMESCO Finland

Percutaneous utlrasound examination fo prostata

4.2

39.3

125

178

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

39.0

401

1131

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

38.7

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

38.7

5BX04, ,

NOMESCO Finland

+∞

38.7

A28

ICPC

Limited function/disability NOS

1.4

38.4

2052

9020

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

146.1

38.3

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.1

38.2

115

D40.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified

8.5

38.2

N02AA01

ATC

morphine; systemic, rectal

3.0

38.0

195

390

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.8

38.0

225

489

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

37.9

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

37.9

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.3

37.8

163

292

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

5.9

37.7

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.0

37.6

TQX05

NOMESCO Finland

Skin puncture, unspecified location

11.3

37.5

ZX100

NOMESCO Finland

Oral

3.1

37.1

181

351

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

37.1

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

37.1

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

37.1

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

37.1

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

36.9

1450

6013

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.8

36.9

M05BA02

ATC

clodronic acid; systemic

74.5

36.9

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

36.8

4048

19824

J01MA06

ATC

norfloxacin; oral

1.6

36.6

1056

4094

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

17.1

36.6

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.5

36.6

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

17.9

36.4

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

36.2

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

36.2

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

36.2

KBJ60

NOMESCO Finland

Anastomosis of ureter to urethra with interposition of ileum

+∞

36.2

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

73.0

36.1

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

4.7

35.9

100

127

ZXF10

NOMESCO Finland

Interruption caused by technical failure of equipment

11.5

35.7

SPAT1325

SPAT

Vaccination

1.3

35.6

3883

18982

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

3.9

35.6

122

185

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

35.4

1814

7907

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

35.4

WB201

NOMESCO Finland

Simple neoadjuvant hormone therapy of malignancy

+∞

35.4

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

35.4

KE099

NOMESCO Finland

Other radiotherapy of prostata and seminal vesicles

+∞

35.4

KE1DM

NOMESCO Finland

Very extensive MRI of prostate (more than 1.5 T)

71.5

35.3

XKC03

NOMESCO Finland

Water cystometry

2.3

35.1

292

752

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

58.4

35.1

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

91.4

34.7

J01DB01

ATC

cefalexin; oral

1.3

34.6

10377

57053

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

34.5

B01AB04

ATC

dalteparin; parenteral

1.9

34.4

494

1575

GDC00

NOMESCO Finland

Lobectomy of lung

8.8

34.2

A98

ICPC

Health maint/preventive medicine

1.4

34.1

12595

71093

ZQZ00

NOMESCO Finland

Treatment of several skin areas

9.2

34.0

A07EA02

ATC

hydrocortisone; rectal

2.4

33.8

263

657

KA1FN

NOMESCO Finland

Isotope renography

5.4

33.7

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

33.7

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

33.7

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

9.3

33.6

N42.8

ICD-10 Finland

Other specified disorders of prostate

4.3

33.5

103

143

ZXA10

NOMESCO Finland

Bilateral

1.4

33.2

1968

8788

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

87.4

33.0

KE003

NOMESCO Finland

Adjuvant radiotherapy of prostata and seminal vesicles

+∞

32.8

C67.1

ICD-10 Finland

Malignant neoplasm: Dome of bladder

+∞

32.8

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

32.8

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

32.7

3393

16444

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

13.6

31.8

G04BD07

ATC

tolterodine; oral

1.9

31.7

479

1553

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

31.2

11144

62052

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

4.7

31.1

111

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

14.5

31.1

S82

ICPC

Naevus/mole

1.5

31.1

1138

4645

SPAT1262

SPAT

Handing over of treatment supplies

1.3

30.9

2410

11215

ZZA50

NOMESCO Finland

Full thickness skin graft

8.1

30.7

U08

ICPC

Urinary retention

2.0

30.6

397

1222

R86

ICD-10 Finland

Abnormal findings in specimens from male genital organs

8.8

30.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

225.5

30.5

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

30.3

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

30.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

30.3

L01CA04

ATC

vinorelbine; systemic

+∞

30.3

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

30.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

30.3

L01CB01

ATC

etoposide; systemic

+∞

30.3

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

30.3

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

116.2

30.1

8148/2-C61.9

ICD-O-3

Glandular intraepithelial neoplasia, high grade of prostate gland

5.5

30.0

JFB30

NOMESCO Finland

Right hemicolectomy

4.0

30.0

102

154

WX704

NOMESCO Finland

Intubation

1.6

29.9

816

3120

SPAT1167

SPAT

Insertion of urinary catheter

1.8

29.9

490

1631

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

50.1

29.5

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

29.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

29.5

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

29.5

OAA41

NOMESCO Finland

Health check based on individual needs

37.4

29.4

G04BD11

ATC

fesoterodine; oral

2.1

29.4

309

880

8120/2-C67.9

ICD-O-3

Urothelial carcinoma in situ of bladder, NOS

77.5

29.0

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

213.5

28.8

SPAT1254

SPAT

Administration of medicine

1.4

28.8

1597

7042

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

28.6

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

28.6

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

28.6

L02AA02

ATC

polyestradiol phosphate; parenteral

+∞

28.6

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

28.6

U13

ICPC

Bladder symptom/complaint other

2.3

28.5

242

630

SPAT1088

SPAT

Blood transfusion

5.1

28.4

WX600

NOMESCO Finland

Single shot through catheter

5.1

28.4

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

28.4

271

3193

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.9

28.3

410

1311

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

28.1

2134

9879

H02AB06

ATC

prednisolone; systemic

1.2

28.0

5639

29388

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

207.5

28.0

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

28.0

1358

5849

U99

ICPC

Urinary disease other

3.3

27.9

123

224

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

27.8

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

11.9

27.7

Y50

ICPC

Male Genital, Medication/prescr/renewal

6.4

27.6

XW000

NOMESCO Finland

Bone marrow biopsy

1.9

27.3

362

1124

C82.1

ICD-10 Finland

Follicular lymphoma grade II

201.5

27.1

TKD00

NOMESCO Finland

Dilatation of urethra

3.2

27.0

123

229

C61, D400,

ICD-10 Finland

+∞

26.9

C05AA08

ATC

fluocortolone; rectal, topical

1.4

26.9

1509

6661

U28

ICPC

Limited function/disability (U)

2.7

26.8

159

347

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

104.2

26.8

U29

ICPC

Urinary symptom/complaint other

2.0

26.5

305

900

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.3

26.3

220

569

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

26.3

1177

4993

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

2.7

26.2

165

372

N05CF01

ATC

zopiclone; oral

1.3

26.2

3554

17717

SPAT1109

SPAT

Analgesia with portable analgesic pump

5.1

26.1

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

26.1

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

26.1

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

26.1

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

26.1

8010/3-C61.9

ICD-O-3

Carcinoma, NOS, of prostate gland

+∞

26.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.9

26.1

137

279

OAB77

NOMESCO Finland

Discussion on exercise habits and instruction concerning use of sports and fitness services

69.5

25.7

1525, ,

Kela drug reimbursment

+∞

25.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

25.3

KE2KT

NOMESCO Finland

Marker implantation in prostate under radiological guidance

+∞

25.3

3036, ,

Kela drug reimbursment

+∞

25.3

7461

FHL

Needle biopsy in the operating room

3.9

25.2

136

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

4.3

25.1

107

U07

ICPC

Urine symptom/complaint other

1.6

24.8

701

2703

U05

ICPC

Urination problems other

1.6

24.5

635

2397

D06BB10

ATC

imiquimod; topical

1.8

24.4

390

1288

1888X

ICD-9 Finland

Malignant neoplasm of bladder, Other specified sites of bladder

+∞

24.4

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

24.4

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

24.2

2718

13228

KE2AT

NOMESCO Finland

Cytologoy of prostata with ultrasound guidance

11.2

24.0

N21.0

ICD-10 Finland

Calculus in bladder

2.3

24.0

197

506

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

24.0

2175

10303

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

179.5

23.8

SPAT1312

SPAT

General health counselling

1.3

23.8

3138

15562

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

2.9

23.7

124

252

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

23.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

23.6

878

3593

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

23.4

394

1323

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.7

23.3

136

UJG02

NOMESCO Finland

Proctoscopy

2.2

23.2

218

594

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

23.0

2420

11676

KH1AD

NOMESCO Finland

CT of urinary organs

1.7

23.0

450

1579

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

22.7

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

22.7

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

22.7

KAD00

NOMESCO Finland

Partial nephrectomy

7.1

22.7

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

24.5

22.7

SPAT1125

SPAT

Stoma care and guidance

2.5

22.7

159

379

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

89.3

22.7

7455

FHL

Retropubic total prostatectomy

39.3

22.4

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

22.4

3138

21978

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

5.4

22.4

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

5.4

22.4

KCB00

NOMESCO Finland

Biopsy of bladder

6.7

22.2

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.0

22.2

261

777

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.4

22.2

178

453

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.2

21.9

100

187

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

21.9

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

21.9

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

21.9

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

+∞

21.9

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

21.9

L01BC59

ATC

trifluridine, combinations; systemic

+∞

21.9

JN2BM

NOMESCO Finland

Lower part of abdomen MRI examination with Tesla magnet

86.3

21.9

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.8

21.8

380

1289

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.7

21.7

484

1760

153

Kela drug reimbursment

Lenalidomid

46.2

21.6

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

46.2

21.6

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

21.4

2552

12490

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

21.0

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

21.0

KEC10

NOMESCO Finland

Perineal radical prostatectomy

+∞

21.0

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.8

21.0

347

1160

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

57.6

20.9

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.6

20.9

139

323

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.1

20.9

207

577

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

31.8

20.9

Z93.3

ICD-10 Finland

Colostomy status

4.7

20.9

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.9

20.8

113

235

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

8.3

20.7

KDK40

NOMESCO Finland

Removal of artificial urethral sphincter

155.0

20.5

OAB43, ,

SPAT

0.7

20.5

747

6312

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

20.5

8768

48429

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.2

20.3

198

549

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

20.2

KCC20

NOMESCO Finland

Cystoprostatourethrectomy

+∞

20.2

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

20.2

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

20.2

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

20.2

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

4.3

20.2

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

4.6

20.1

KE1CG, ,

SPAT

5.0

20.1

L04AX04

ATC

lenalidomide; oral

43.2

20.1

SPAT1154

SPAT

Insertion or removal of subcutaneous medicine capsule

6.4

20.0

A55

ICPC

General and Unspecified, Local injection/infiltration

2.5

19.9

139

331

-50

ICPC

Medication/prescr/renewal

1.7

19.9

421

1510

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.7

19.9

379

1321

U01

ICPC

Dysuria/painful urination

1.8

19.9

307

1005

D16

ICPC

Rectal bleeding

2.0

19.8

228

674

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.1

19.8

202

570

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

19.8

287

920

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.5

19.8

769

3174

OAA80, ,

SPAT

0.6

19.6

284

2953

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

1.7

19.4

356

1227

WX002

NOMESCO Finland

Sedation and analgesia

1.3

19.4

1986

9535

KEW98

NOMESCO Finland

Other transluminal endoscopic operation on prostate

+∞

19.4

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

19.4

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

19.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

19.4

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

19.4

1CD04, ,

NOMESCO Finland

+∞

19.4

C16.00

ICD-10 Finland

Cardia

+∞

19.4

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

19.4

WX224

NOMESCO Finland

Blockade of obturius nerve

41.7

19.3

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

41.7

19.3

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

19.2

178

483

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

9.4

19.2

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

3.6

19.2

118

KCH42

NOMESCO Finland

Transurethral incision or resection of bladder neck

3.8

19.1

107

KH1DD

NOMESCO Finland

CT urography of urinary organs

5.2

18.9

KCV22

NOMESCO Finland

Transluminal endoscopic evacuation of blood clots from bladder

4.7

18.8

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

3.9

18.8

100

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

3.8

18.7

103

WVA20, ,

SPAT

1.9

18.7

254

797

OAB75

NOMESCO Finland

Nutritional guidance related to maintaining health

25.5

18.7

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

74.4

18.6

SPAT1301

SPAT

No procedures

1.2

18.6

3418

17479

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

18.5

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

18.5

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

18.5

C60.9

ICD-10 Finland

Malignant neoplasm: Penis, unspecified

+∞

18.5

197

Kela drug reimbursment

Sunitinib

+∞

18.5

KE2JT

NOMESCO Finland

Demanding radiation source placement in prostate under ultrasound guidance

+∞

18.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

18.5

1332

6099

SPAT1263

SPAT

Sampling

1.2

18.4

4406

23085

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.4

18.4

140

348

C08CA01

ATC

amlodipine; oral

1.2

18.4

5272

28059

BAA60

NOMESCO Finland

Total thyroidectomy

3.2

18.3

155

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.2

18.2

745

KDV20

NOMESCO Finland

Submucous urethral injection

11.1

18.2

KC1GD

NOMESCO Finland

CT cystography of bladder

13.0

18.2

U50

ICPC

Urological, Medication/prescr/renewal

13.0

18.2

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

5.4

18.1

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.6

18.1

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

136.9

18.0

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

24.7

17.9

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

17.8

4594

24210

A21

ICPC

Risk factor for malignancy

27.8

17.8

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

7.6

17.8

WPB10

NOMESCO Finland

Making a convalescent care decision

7.6

17.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

17.8

616

2484

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

7.0

17.7

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.6

17.7

116

268

D64.8

ICD-10 Finland

Other specified anaemias

2.0

17.7

203

600

329

Kela drug reimbursment

Lenalidomide

38.7

17.7

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

17.7

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

17.7

WB211

NOMESCO Finland

Neoadjuvant hormone therapy of malignancy

+∞

17.7

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

17.7

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

17.7

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

17.7

C60.0

ICD-10 Finland

Malignant neoplasm: Prepuce

+∞

17.7

KED76

NOMESCO Finland

TUVP

2.3

17.6

145

374

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

17.6

947

4143

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.5

17.5

560

2220

A07DA03

ATC

loperamide; oral

1.7

17.5

372

1337

SPAT1053

SPAT

Memory test

1.3

17.5

1873

9033

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

17.4

4239

22222

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.8

17.4

101

219

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

17.2

506

1969

JAH01

NOMESCO Finland

Laparoscopy

2.0

17.2

196

578

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

130.9

17.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

17.2

1319

6090

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.5

17.0

501

1950

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

68.4

17.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

17.0

1149

5212

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

16.9

677

2809

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

16.9

1843

8903

H91.1

ICD-10 Finland

Presbycusis

1.4

16.9

770

3273

UKB02

NOMESCO Finland

Retrograde ureteroscopy

2.3

16.9

135

344

WC225

NOMESCO Finland

Demanding therapy of local tumor recidive with hormone

+∞

16.8

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

16.8

8120/3-C67.2

ICD-O-3

Transitional cell carcinoma, NOS, of lateral wall of bladder

+∞

16.8

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

16.8

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

16.8

180

Kela drug reimbursment

Interferon alfa

+∞

16.8

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

16.8

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

16.8

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

16.8

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

16.8

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

16.8

WC205

NOMESCO Finland

Simple therapy of local tumor recidive with hormone

+∞

16.8

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

16.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

16.8

Z51.88

ICD-10 Finland

Other specified medical care

2.0

16.7

202

609

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.7

16.7

320

1119

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

5.7

16.6

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

20.8

16.6

KWA00

NOMESCO Finland

Repair of wound dehiscence in urological surgery

20.8

16.6

6000A

ICD-9 Finland

Hyperplasia of prostate[HYPERPLASIA PROSTATAE]

1.8

16.6

292

996

R60.0

ICD-10 Finland

Localized oedema

1.3

16.5

1256

5794

7451

FHL

Transurethral adenoma removal

1.9

16.5

212

654

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

5.3

16.4

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

5.3

16.4

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

125.0

16.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

16.2

515

2039

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

29.8

16.2

U71

ICPC

Cystitis/urinary infection other

2.0

16.2

197

596

N05AA02

ATC

levomepromazine; systemic

0.5

16.1

184

2046

-44

ICPC

Preventive immunization/medic

1.4

16.1

808

3494

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

16.0

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

16.0

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

16.0

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

16.0

C45.0

ICD-10 Finland

Mesothelioma of pleura

+∞

16.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

15.9

3027

20720

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

5.4

15.9

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

15.9

538

2160

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

15.9

513

4436

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

15.7

437

1680

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

15.7

219

695

WX290

NOMESCO Finland

Other blockage of nerve

1.2

15.6

4293

22690

N02AA03

ATC

hydromorphone; systemic, rectal

6.0

15.6

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

119.0

15.6

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

119.0

15.6

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

15.5

770

3324

A10BA02

ATC

metformin; oral

0.8

15.5

3380

22873

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

15.3

3395

22951

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

15.3

131

345

C60.1

ICD-10 Finland

Malignant neoplasm: Glans penis

+∞

15.2

115

Kela drug reimbursment

Breast cancer

+∞

15.2

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

15.2

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

+∞

15.2

L02AB02

ATC

medroxyprogesterone; systemic

+∞

15.2

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

15.2

8070/3-C32.0

ICD-O-3

Squamous cell carcinoma, NOS, of glottis

+∞

15.2

C68.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of urinary organs

+∞

15.2

8070/3-C32.9

ICD-O-3

Squamous cell carcinoma, NOS, of larynx, NOS

+∞

15.2

HAC20

NOMESCO Finland

Total mastectomy

19.4

15.1

Z93.6

ICD-10 Finland

Other artificial openings of urinary tract status

19.4

15.1

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

15.1

417

1602

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.9

15.0

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

15.0

337

1231

1530

FHL

Urethrocystoscopy

1.8

14.9

226

737

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

1.7

14.9

270

930

N04AA02

ATC

biperiden; systemic

0.3

14.9

824

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

14.9

820

3603

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

23.8

14.8

D06BX02

ATC

ingenol mebutate; topical

2.5

14.8

106

257

TQB05

NOMESCO Finland

Puncture of skin of trunk

4.5

14.8

KCC00

NOMESCO Finland

Cystectomy

113.0

14.8

N30

ICD-10 Finland

Cystitis

1.7

14.7

270

933

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.5

14.7

103

247

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

14.7

2418

12200

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

32.7

14.6

D09.0

ICD-10 Finland

Carcinoma in situ: Bladder

59.5

14.6

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

3.1

14.6

133

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.7

14.5

266

919

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.8

14.5

179

S50

ICPC

Skin, Medication/prescr/renewal

2.8

14.4

180

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.7

14.3

299

1071

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

14.3

690

2963

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

14.3

3752

19724

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

14.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

14.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

14.3

L01XE04

ATC

[U] sunitinib

+∞

14.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

14.3

KE1AK

NOMESCO Finland

Spectroscopy of prostate

+∞

14.3

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

14.3

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

+∞

14.3

8070/3-C09.9

ICD-O-3

Squamous cell carcinoma, NOS, of tonsil, NOS

+∞

14.3

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

14.3

N48.4

ICD-10 Finland

Impotence of organic origin

1.5

14.2

455

1806

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.2

14.2

631

A10AA02, ,

ATC

0.5

14.2

131

1556

A10AC01

ATC

insulin (human); parenteral

0.7

14.0

518

4370

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

14.0

1551

7499

C03CA01

ATC

furosemide; systemic

1.2

14.0

4175

22168

H02AB07

ATC

prednisone; oral

1.3

14.0

1316

6240

B03XA02

ATC

darbepoetin alfa; parenteral

1.8

13.9

217

715

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

13.9

2483

12622

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

31.2

13.8

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

4.2

13.8

JJB10

NOMESCO Finland

Atypcal resection of liver

56.5

13.8

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

39.7

13.8

U02

ICPC

Urinary frequency/urgency

1.4

13.6

796

3530

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

3.9

13.6

G04AC01, ,

ATC

2.4

13.6

239

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

13.6

5299

28689

7323

FHL

Electrosection of TU bladder wall change

19.6

13.5

NF3AA

NOMESCO Finland

Femur X-ray examination

1.9

13.5

195

627

D03.5

ICD-10 Finland

Melanoma in situ of trunk

4.5

13.5

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

+∞

13.5

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

13.5

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

13.5

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

13.5

198

Kela drug reimbursment

Sorafenib

+∞

13.5

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

13.5

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

13.5

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

+∞

13.5

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

13.5

C34.89

ICD-10 Finland

Malignant overall tumor of the bronchus and lung other or unspecified histology

+∞

13.5

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

13.5

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

+∞

13.5

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

13.4

1509

7311

J05AB01

ATC

aciclovir; systemic

1.2

13.3

1655

8105

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

3.0

13.3

128

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.4

13.2

1013

N41.0

ICD-10 Finland

Acute prostatitis

1.5

13.2

379

1469

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.8

13.2

2724

18569

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.4

13.2

577

2437

D77

ICPC

Malignant digestive neopl other/NOS

25.0

13.2

L95

ICPC

Osteoporosis

2.1

13.2

131

368

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.5

13.1

449

1809

Y26

ICPC

Fear of genital cancer male

5.4

13.1

WW300

NOMESCO Finland

Transfer of autologic stem cells

29.7

13.1

D29.1

ICD-10 Finland

Benign neoplasm: Prostate

2.4

13.0

240

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

13.0

177

558

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

53.6

13.0

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

37.6

13.0

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

17.1

13.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.8

13.0

203

670

K92.1

ICD-10 Finland

Melaena

1.4

12.9

644

2783

KC1AT

NOMESCO Finland

Puncture of urinary bladder with ultrasound guidance

3.9

12.8

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

12.8

206

686

KCD30

NOMESCO Finland

Destruction of tumour of bladder

18.7

12.8

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

12.8

647

2804

A10BK03

ATC

empagliflozin; oral

0.8

12.7

867

6653

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.8

12.7

145

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

12.7

3140

16405

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.1

12.7

116

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

12.6

174

551

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

12.6

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

12.6

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

12.6

8041/3-C61.9

ICD-O-3

Small cell carcinoma, NOS, of prostate gland

+∞

12.6

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

12.6

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

12.6

L01AX03

ATC

temozolomide; systemic

+∞

12.6

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

12.6

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

+∞

12.6

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

12.6

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

12.6

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

12.6

189

Kela drug reimbursment

Imatinib

+∞

12.6

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

12.6

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

+∞

12.6

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

12.6

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

12.6

U79

ICPC

Neoplasm urinary tract unspecified

20.8

12.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

12.6

475

1952

8130/1-C67.9

ICD-O-3

Papillary urothelial neoplasm of low malignant potential of bladder, NOS

15.2

12.5

N35.8

ICD-10 Finland

Other urethral stricture

2.8

12.5

143

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.8

12.5

2732

18542

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

23.8

12.4

SPAT1211

SPAT

Application of soft bandage

1.3

12.4

787

3534

S21

ICPC

Skin texture symptom/complaint

1.3

12.3

1289

6188

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

7.2

12.3

5BA08, ,

NOMESCO Finland

3.7

12.3

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

28.3

12.3

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

95.2

12.3

JLC30

NOMESCO Finland

Pancreatoduodenectomy

5.3

12.3

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

12.3

3082

16112

C43

ICD-10 Finland

Malignant melanoma of skin

16.4

12.3

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

50.6

12.2

KAC21

NOMESCO Finland

Percutaneous endoscopic nephroureterectomy

50.6

12.2

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

50.6

12.2

J01CA04

ATC

amoxicillin; systemic

1.1

12.2

9292

52460

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.0

12.2

134

392

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.1

12.2

125

356

P72

ICPC

Schizophrenia

0.3

12.1

581

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

12.1

1353

6547

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

17.9

12.1

H25.8

ICD-10 Finland

Other senile cataract

1.3

12.0

1217

5819

-55

ICPC

Local injection/infiltration

2.5

12.0

188

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.4

12.0

868

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

0.7

11.9

497

4105

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

6.2

11.9

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.2

11.9

2223

11331

KWW96

NOMESCO Finland

Other reoperation in urological surgery

19.8

11.9

C44

ICD-10 Finland

Other malignant neoplasms of skin

6.8

11.9

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.8

11.8

194

650

18599

ICD-8 Finland

Malignant neoplasm of prostate

+∞

11.8

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

+∞

11.8

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

11.8

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

+∞

11.8

C44.19

ICD-10 Finland

Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology

+∞

11.8

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

11.8

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

11.8

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

11.8

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

11.8

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

11.8

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

11.8

C67.5

ICD-10 Finland

Malignant neoplasm: Bladder neck

+∞

11.8

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.5

11.8

439

1800

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

4.3

11.7

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

1.5

11.7

356

1399

OAA67, ,

SPAT

0.7

11.7

460

3839

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

11.7

1771

8846

S29

ICPC

Skin symptom/complaint other

1.2

11.6

1732

8639

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.0

11.6

128

375

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

1.9

11.6

154

483

U75

ICPC

Malignant neoplasm of kidney

26.8

11.5

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.3

11.5

262

Z3226

NOMESCO Finland

Physiotherapist

1.2

11.5

1726

8613

H26.4

ICD-10 Finland

After-cataract

1.3

11.5

901

4171

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

89.2

11.5

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

33.7

11.4

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.2

11.4

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

47.6

11.4

Z93

ICD-10 Finland

Artificial opening status

6.5

11.4

KED33

NOMESCO Finland

Transurethral incision of prostate

1.6

11.3

267

989

G04CB01

ATC

finasteride; oral

1.2

11.3

2575

13343

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.5

11.3

351

1386

H02

ICPC

Hearing complaint

1.2

11.3

1583

7846

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

3.9

11.2

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.5

11.2

191

R15

ICD-10 Finland

Faecal incontinence

2.1

11.2

119

344

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.5

11.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

11.1

4493

24291

L01AA02

ATC

chlorambucil; oral

18.8

11.1

R84

ICPC

Malignant neoplasm bronchus/lung

13.9

11.1

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

2.2

11.1

105

290

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.3

11.0

237

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

3.8

11.0

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.2

11.0

1450

7141

I50.1

ICD-10 Finland

Left ventricular failure

0.7

11.0

490

4003

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

6.2

11.0

SPAT1168

SPAT

Catheterisation training

2.4

11.0

215

KE029

NOMESCO Finland

Radiotherapy of local recidive of tumor of prostata and seminal vesicles

+∞

10.9

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

10.9

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

10.9

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

+∞

10.9

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

10.9

2AE02, ,

NOMESCO Finland

+∞

10.9

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

10.9

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

10.9

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

+∞

10.9

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

10.9

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

10.9

NA049

NOMESCO Finland

Radiotherapy of methastasis in spine

+∞

10.9

M05BA08

ATC

zoledronic acid; parenteral

11.9

10.9

R53

ICD-10 Finland

Malaise and fatigue

1.2

10.9

2122

10848

SPAT1043

SPAT

Audiometry

1.3

10.9

1124

5387

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

3.6

10.9

N05AH03

ATC

olanzapine; systemic

0.6

10.9

227

2147

S26

ICPC

Fear of cancer of skin

2.5

10.9

183

N05AH02

ATC

clozapine; systemic

0.2

10.8

485

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1.4

10.8

520

2235

KGH10

NOMESCO Finland

Operation for phimosis

1.4

10.8

430

1786

GD1AD

NOMESCO Finland

Thorax CT examination

1.4

10.8

555

2412

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

10.8

3627

19355

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.5

10.8

344

1367

N13.8

ICD-10 Finland

Other obstructive and reflux uropathy

5.5

10.7

WPA13

NOMESCO Finland

Palliative consultation

4.9

10.7

Z10.0

ICD-10 Finland

Occupational health examination

0.6

10.7

260

2377

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

31.7

10.7

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

83.3

10.7

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

83.3

10.7

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

83.3

10.7

C64.80

ICD-10 Finland

Wilms tumour

83.3

10.7

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

83.3

10.7

N99.5

ICD-10 Finland

Malfunction of external stoma of urinary tract

5.7

10.7

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.3

10.7

JR1AS

NOMESCO Finland

Restricted PET-MRI of receptors/transporters in body

44.6

10.6

N03AG01

ATC

valproic acid; systemic, rectal

0.7

10.6

272

2458

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

4.7

10.6

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.7

10.5

L28

ICPC

Limited function/disability (L)

1.2

10.5

1783

9005

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.2

10.4

243

ZX114

NOMESCO Finland

Intramuscular

2.1

10.4

103

290

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

10.3

690

3125

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

10.3

709

3224

UDC00

NOMESCO Finland

Ear microscopy

1.3

10.3

721

3287

H13

ICPC

Plugged feeling ear

1.2

10.2

2310

11955

EDB00

NOMESCO Finland

Partial excision of mandible

20.2

10.2

N05AA01

ATC

chlorpromazine; systemic, rectal

0.3

10.2

524

XQ848

NOMESCO Finland

Dermatological photography

1.7

10.2

211

758

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

10.1

542

2372

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

2.7

10.1

126

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

2.8

10.1

116

KBJ80

NOMESCO Finland

Operation for malfunction of urinary diversion

+∞

10.1

JGB36

NOMESCO Finland

Wide excision of rectum

+∞

10.1

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

10.1

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

10.1

C44.00

ICD-10 Finland

Malignant tumor of the lip skin without histology

+∞

10.1

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

10.1

UKC12

NOMESCO Finland

Retrograde endoscopy of cutaneous cystoenterostomy

+∞

10.1

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

10.1

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

10.1

C68.0

ICD-10 Finland

Malignant neoplasm: Urethra

+∞

10.1

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

10.1

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

10.1

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

10.1

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

+∞

10.1

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

10.1

369

Kela drug reimbursment

Regorafenib

+∞

10.1

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

10.1

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

10.1

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

10.1

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

10.1

L01XE01

ATC

[U] imatinib

+∞

10.1

N07BC02

ATC

methadone; systemic

3.9

10.1

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

7.1

10.0

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

23.8

10.0

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

0.5

10.0

1057

Z43.5

ICD-10 Finland

Attention to cystostomy

2.1

10.0

275

OAA65, ,

SPAT

0.7

10.0

379

3179

TKC50

NOMESCO Finland

Training of urinary bladder

3.7

10.0

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

4.3

9.9

G04BD09

ATC

trospium; oral

1.7

9.9

173

593

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

77.3

9.9

ZX137

NOMESCO Finland

To penis

77.3

9.9

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

77.3

9.9

PJD99

NOMESCO Finland

Excision of other lymph nodes

77.3

9.9

399

Kela drug reimbursment

Venetoclax

77.3

9.9

H81

ICPC

Excessive ear wax

1.2

9.8

2141

11044

4194, ,

NOMESCO Finland

41.7

9.8

Y77

ICD-10 Finland

Ophthalmic devices associated with adverse incidents

41.7

9.8

H3601, E113,

ICD-10 Finland

0.4

9.8

829

A29

ICPC

General symptom/complaint other

1.2

9.8

1196

5842

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

2.2

9.8

254

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

3.7

9.8

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.6

9.8

262

1003

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

9.8

1520

7609

S08

ICPC

Skin colour change

1.4

9.8

424

1792

KBV10

NOMESCO Finland

Removal of stent from ureter

2.2

9.7

235

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

5.7

9.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.6

9.7

212

772

HA1AA

NOMESCO Finland

X-ray mammography

3.3

9.7

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.8

9.7

152

504

R77.8

ICD-10 Finland

Other specified abnormalities of plasma proteins

4.6

9.7

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

16.9

9.7

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

5.9

9.7

N05AC02

ATC

thioridazine; oral

0.4

9.6

705

TQX20

NOMESCO Finland

Implantation of subcutaneous medicament implant

3.7

9.6

N05AF05

ATC

zuclopenthixol; systemic

0.2

9.6

379

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

6.6

9.6

H84

ICPC

Presbyacusis

1.4

9.6

396

1659

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

2.7

9.6

120

N03AX16

ATC

[U] pregabalin

1.2

9.5

2183

11305

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.9

9.5

N05AX08

ATC

risperidone; systemic

0.8

9.5

573

4472

A10AA01, ,

ATC

0.5

9.5

910

KAC00

NOMESCO Finland

Nephrectomy

5.3

9.5

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

19.0

9.5

KH1RT

NOMESCO Finland

Urinary tract dilatatation with radiological guidance

19.0

9.5

Z31.5

ICD-10 Finland

Genetic counselling

1.7

9.5

174

605

N05AF03

ATC

chlorprothixene; systemic

0.5

9.5

981

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

4.8

9.4

ZX110

NOMESCO Finland

Intracutaneous

4.1

9.4

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

3.5

9.3

JFB43

NOMESCO Finland

Left hemicolectomy

3.3

9.3

A10AB01

ATC

insulin (human); parenteral

0.6

9.3

129

1349

XKD11, ,

NOMESCO Finland

5.7

9.3

N32.0

ICD-10 Finland

Bladder-neck obstruction

1.8

9.3

157

533

KE1DG, ,

SPAT

4.9

9.3

C32.9

ICD-10 Finland

Malignant neoplasm: Larynx, unspecified

+∞

9.3

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

9.3

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

9.3

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

9.3

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

9.3

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

9.3

8070/3-C01.9

ICD-O-3

Squamous cell carcinoma, NOS, of base of tongue, NOS

+∞

9.3

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

9.3

8000/3-C34.3

ICD-O-3

Neoplasm, malignant of lower lobe, lung

+∞

9.3

L02BX04

ATC

relugolix; oral

+∞

9.3

8120/3-C65.9

ICD-O-3

Transitional cell carcinoma, NOS, of renal pelvis

+∞

9.3

9823/3-C77.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS

+∞

9.3

Z85.5

ICD-10 Finland

Personal history of malignant neoplasm of urinary tract

+∞

9.3

191

Kela drug reimbursment

Erlotinib

+∞

9.3

TKC00

NOMESCO Finland

Needle biopsy of bladder

9.9

9.2

WPA43, ,

SPAT

14.4

9.2

N41.2

ICD-10 Finland

Abscess of prostate

6.3

9.2

L02BA01

ATC

tamoxifen; oral

5.1

9.1

T81.9

ICD-10 Finland

Unspecified complication of procedure

1.8

9.1

145

483

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.5

9.1

326

1328

KDK30

NOMESCO Finland

Revision of artificial urethral sphincter

27.8

9.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

9.1

2373

12409

7321

FHL

TU biopsy, coagulation or laser

3.8

9.1

ZXA00

NOMESCO Finland

Right side

1.2

9.1

2810

14887

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

71.4

9.0

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

71.4

9.0

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

71.4

9.0

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

71.4

9.0

1518, ,

Kela drug reimbursment

71.4

9.0

JJB71

NOMESCO Finland

Laparoscopic resection of liver

71.4

9.0

4CX01, ,

NOMESCO Finland

71.4

9.0

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

38.7

9.0

ECB20

NOMESCO Finland

Oral alveoplasty

2.0

9.0

105

316

C10AX09

ATC

ezetimibe; oral

0.8

9.0

1706

11748

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.1

9.0

2906

15442

SPAT1255

SPAT

Intravenous administration of medicine

1.3

8.9

699

3237

GA5AA

NOMESCO Finland

Rib X-ray examination

3.5

8.9

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

5.4

8.9

A07AA02

ATC

nystatin; oral

1.4

8.9

391

1657

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

2.8

8.9

108

A10BB01

ATC

glibenclamide; oral

0.7

8.8

350

2912

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

3.8

8.8

Z3229

NOMESCO Finland

Other healthcare associate professional

1.3

8.8

831

3941

KC1AE

NOMESCO Finland

Percutaneous ultrasound examination of urinary bladder

3.1

8.8

A10AE04

ATC

insulin glargine; parenteral

0.8

8.8

848

6238

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

12.6

8.8

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

0.2

8.8

227

KDE12

NOMESCO Finland

Urethroscopic extraction of calculus of urethra

17.8

8.7

N06AX21

ATC

duloxetine; oral

1.3

8.7

770

3622

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

3.3

8.7

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.8

8.7

618

4717

I42.0

ICD-10 Finland

Dilated cardiomyopathy

0.6

8.7

216

1961

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.8

8.7

147

500

A02BC01

ATC

omeprazole; systemic

1.1

8.7

2885

15354

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.3

8.6

728

3405

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

1.8

8.6

143

483

F29

ICD-10 Finland

Unspecified nonorganic psychosis

0.5

8.6

780

N06AX11

ATC

mirtazapine; oral

1.1

8.6

3117

16681

SAA03

NOMESCO Finland

Extended examination of mouth

1.1

8.6

3395

18275

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.6

8.6

140

1400

I25.2

ICD-10 Finland

Old myocardial infarction

0.8

8.5

846

6198

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

2.6

8.5

125

N05AX12

ATC

aripiprazole; systemic

0.4

8.5

741

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

0.8

8.4

578

4430

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

+∞

8.4

322

Kela drug reimbursment

Sunitinib

+∞

8.4

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

8.4

KCJ10

NOMESCO Finland

Cutaneous cystoenterostomy

+∞

8.4

C09.9

ICD-10 Finland

Malignant neoplasm: Tonsil, unspecified

+∞

8.4

C38.1

ICD-10 Finland

Malignant neoplasm: Anterior mediastinum

+∞

8.4

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

8.4

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

8.4

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

8.4

C62.99

ICD-10 Finland

Malignant tumor in unspecified location in testis,other or undetermined histology

+∞

8.4

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

8.4

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

8.4

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

8.4

1512

Kela drug reimbursment

Ibrutinib

+∞

8.4

C62.00

ICD-10 Finland

Malignant tumor of the non-descending testicle, no histological verification

+∞

8.4

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

8.4

L01EA01

ATC

imatinib; oral

+∞

8.4

159

Kela drug reimbursment

Pazopanib

+∞

8.4

C80.98

ICD-10 Finland

Malignant tumor without specified localization other specified histology

+∞

8.4

L01AA04, ,

ATC

+∞

8.4

YN7VG

NOMESCO Finland

MRI examination of spine with high intesinty magnet for dose design of radiotherapy

+∞

8.4

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

8.4

PJD98

NOMESCO Finland

Other block dissection of lymph nodes

+∞

8.4

390

Kela drug reimbursment

Ibrutinib

+∞

8.4

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

+∞

8.4

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

2.9

8.4

N02

ICD-10 Finland

Recurrent and persistent haematuria

3.6

8.4

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

11.2

8.4

KBD00

NOMESCO Finland

Partial excision of ureter

25.8

8.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.1

8.4

4959

27334

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.2

8.3

1043

5108

D22

ICD-10 Finland

Melanocytic naevi

1.5

8.3

255

1008

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

5.9

8.3

ZXA05

NOMESCO Finland

Left side

1.1

8.3

2593

13736

F20.5

ICD-10 Finland

Residual schizophrenia

0.2

8.3

232

Z01.9

ICD-10 Finland

Special examination, unspecified

1.3

8.3

497

2218

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.1

8.3

240

S04

ICPC

Lump/swelling localized

1.3

8.3

755

3568

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

35.7

8.3

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

0.6

8.3

177

1659

8130/2-C67.2

ICD-O-3

Papillary urothelial carcinoma, non-invasive of lateral wall of bladder

65.4

8.2

B72

ICPC

Hodgkin Lymphoma

65.4

8.2

L01XX52

ATC

venetoclax; oral

65.4

8.2

C84.0

ICD-10 Finland

Mycosis fungoides

65.4

8.2

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

65.4

8.2

UKC22

NOMESCO Finland

Urethroneocystoscopy

65.4

8.2

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

65.4

8.2

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

65.4

8.2

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

2.5

8.2

134

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

3.1

8.2

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

2.9

8.2

S15

ICPC

Foreign body in skin

1.3

8.2

569

2596

A02BC05

ATC

esomeprazole; systemic

1.1

8.2

4126

22532

XA800

NOMESCO Finland

Neuropsychological investigation

0.7

8.1

213

1913

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.6

8.1

183

673

N21.1

ICD-10 Finland

Calculus in urethra

2.7

8.1

110

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.1

8.1

214

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

0.6

8.1

155

1492

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

1.9

8.1

114

366

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.3

8.1

815

3896

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.6

8.1

142

1395

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

2.8

8.1

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

8.1

3949

21518

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

8.1

1606

8216

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.2

8.1

346

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.7

8.1

400

3208

XQ845

NOMESCO Finland

Dermatoscopy

1.8

8.0

120

393

YNB10

NOMESCO Finland

Collection of stem cells for transplant

16.7

8.0

TKE05

NOMESCO Finland

Aspiration cytology of prostate

10.1

8.0

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

4.1

8.0

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

8.0

173

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.3

8.0

681

3191

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.5

8.0

TGD00

NOMESCO Finland

Needle biopsy of lung

3.4

8.0

WX872

NOMESCO Finland

Intensive care

0.7

7.9

448

3524

A06AC51

ATC

ispaghula, combinations; oral

1.4

7.9

346

1467

RD211, ,

NOMESCO Finland

1.4

7.9

359

1533

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

2.8

7.9

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

2.5

7.9

130

ZXB10

NOMESCO Finland

Medial

2.3

7.8

167

WX400

NOMESCO Finland

Inhalation anesthesy

1.5

7.8

259

1041

A97

ICPC

No disease

1.2

7.8

1652

8494

N05AB03

ATC

perphenazine; systemic, rectal

0.6

7.8

132

1307

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.4

7.8

424

1865

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

4.5

7.8

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

2.6

7.8

113

OAB48, ,

SPAT

0.7

7.7

408

3242

R60.9

ICD-10 Finland

Oedema, unspecified

1.3

7.7

456

2031

KA3LT

NOMESCO Finland

Njurlesion coagulation

10.6

7.7

UJF34

NOMESCO Finland

Left colonoscopy

2.5

7.7

124

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.3

7.7

729

3462

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.8

7.7

611

4595

R86.2

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of other drugs, medicaments and biological substances

8.2

7.7

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

0.5

7.6

729

A10AB04

ATC

insulin lispro; parenteral

0.6

7.6

114

1165

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.1

7.6

3366

18222

B01AE07

ATC

dabigatran etexilate; oral

1.3

7.6

456

2037

C34.21

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma

+∞

7.6

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

7.6

C34.20

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung without histology

+∞

7.6

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

+∞

7.6

NE049

NOMESCO Finland

Radiotherapy of methastasis in pelvis, sacrum or coggyx

+∞

7.6

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

7.6

C44.09

ICD-10 Finland

Malignant tumor of the lip skin other or unspecified histology

+∞

7.6

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

7.6

1889X

ICD-9 Finland

Malignant neoplasm of bladder, Bladder, part unspecified

+∞

7.6

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

+∞

7.6

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

7.6

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

+∞

7.6

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

7.6

8000/3-C67.9

ICD-O-3

Neoplasm, malignant of bladder, NOS

+∞

7.6

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

7.6

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

7.6

C49.2

ICD-10 Finland

Malignant neoplasm: Connective and soft tissue of lower limb, including hip

+∞

7.6

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

7.6

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

+∞

7.6

C80.91

ICD-10 Finland

Malignant tumor without specified localization epidermoid carcinoma

+∞

7.6

L01XE03

ATC

[U] erlotinib

+∞

7.6

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

+∞

7.6

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

7.6

C79.40

ICD-10 Finland

Secondary malignant tumor of the spinal cord

+∞

7.6

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

7.6

C15.1

ICD-10 Finland

Malignant neoplasm: Thoracic part of oesophagus

+∞

7.6

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

7.6

C34.15

ICD-10 Finland

Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma

+∞

7.6

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

7.6

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

7.6

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

7.6

29599

ICD-8 Finland

Schizophrenia, Unspecified type

0.2

7.6

229

J05AB11

ATC

valaciclovir; oral

1.2

7.5

997

4914

F20.0

ICD-10 Finland

Paranoid schizophrenia

0.2

7.5

218

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

0.7

7.5

376

3009

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

32.7

7.5

G04BXXX, ,

ATC

32.7

7.5

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.2

7.5

167

WPA44, ,

SPAT

5.6

7.5

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

3.8

7.5

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

0.5

7.4

912

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.3

7.4

446

1992

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

59.5

7.4

WE198

NOMESCO Finland

Palliative cystotatic therapy

59.5

7.4

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

59.5

7.4

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

59.5

7.4

SPAT1310

SPAT

Counselling related to known health issue

1.1

7.4

3167

17106

D18

ICPC

Change in faeces/bowel movements

1.6

7.4

158

574

A10AE05

ATC

insulin detemir; parenteral

0.7

7.4

345

2793

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.2

7.4

187

F16

ICPC

Eyelid symptom/complaint

1.4

7.4

338

1445

M01AX05

ATC

glucosamine; oral

1.2

7.4

1738

9012

SPAT1260

SPAT

Consultation of another employee

1.2

7.4

1694

8769

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

0.6

7.3

129

1263

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.7

7.3

373

2977

R11

ICD-10 Finland

Nausea and vomiting

1.3

7.3

525

2407

A10BK01

ATC

dapagliflozin; oral

0.8

7.3

626

4665

114

Kela drug reimbursment

Glaucoma

1.2

7.3

927

4549

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

2.9

7.3

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.4

7.2

271

1118

JFF10

NOMESCO Finland

Loop enterostomy

3.2

7.2

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

0.5

7.2

737

KA3GB

NOMESCO Finland

Retrograde pyelography

4.0

7.2

H01CB03

ATC

lanreotide; parenteral

11.9

7.2

N05CF02

ATC

zolpidem; oral

1.2

7.2

1287

6528

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.5

7.1

221

877

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.4

7.1

331

1419

46309

ICD-8 Finland

Acute tonsillitis, Unspecified

0.7

7.1

238

2036

P01AB01

ATC

metronidazole; oral, rectal

1.1

7.1

3221

17455

R4190

NOMESCO Finland

Nutritional therapy

1.6

7.1

179

679

JFB00

NOMESCO Finland

Partial resection of small intestine

1.8

7.1

113

379

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

7.8

7.1

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

7.8

7.1

KBH20

NOMESCO Finland

Replantation of ureter

8.7

7.0

G04BX04, ,

ATC

1.5

7.0

207

813

SPAT1172

SPAT

Guidance concerning hydration

1.5

7.0

199

775

A04

ICPC

Weakness/tiredness general

1.2

7.0

1124

5644

T89

ICPC

Diabetes insulin dependent

0.6

7.0

160

1474

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

7.0

1122

5635

A10AB05

ATC

insulin aspart; parenteral

0.8

7.0

566

4244

CBA10

NOMESCO Finland

Biopsy of eyelid

2.2

7.0

157

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.3

7.0

645

3056

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.1

7.0

208

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

3.9

6.9

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

6.9

544

2526

D76

ICPC

Malignant neoplasm pancreas

12.9

6.9

NFR30

NOMESCO Finland

Extended excision of soft tissue tumour of hip or thigh

12.9

6.9

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

12.9

6.9

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

21.8

6.9

E0000UV, ,

ATC

1.1

6.8

3700

20246

KCJ00

NOMESCO Finland

Cystostomy

3.6

6.8

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

6.7

6.8

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.7

6.8

139

500

6123

FHL

Radical surgery

1.3

6.8

545

2536

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.2

6.8

1211

6138

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

6.8

250

1029

WPA44

NOMESCO Finland

Nursing home for palliative care

4.5

6.8

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.2

6.8

167

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.3

6.7

414

1857

L03AB05

ATC

interferon alfa-2b; parenteral

4.0

6.7

Y99

ICPC

Genital disease male other

2.8

6.7

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

+∞

6.7

C16.30

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

+∞

6.7

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

6.7

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

6.7

L01BC53

ATC

tegafur, combinations; systemic

+∞

6.7

C00.1

ICD-10 Finland

Malignant neoplasm: External lower lip

+∞

6.7

C67.6

ICD-10 Finland

Malignant neoplasm: Ureteric orifice

+∞

6.7

8000/3-C34.1

ICD-O-3

Neoplasm, malignant of upper lobe, lung

+∞

6.7

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

6.7

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

+∞

6.7

3012

Kela drug reimbursment

Cabozantinib

+∞

6.7

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

+∞

6.7

176

Kela drug reimbursment

Regorafenib

+∞

6.7

8246/3-C80.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of unknown primary site

+∞

6.7

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

6.7

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

6.7

YN2AS, ,

NOMESCO Finland

+∞

6.7

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

6.7

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

6.7

L01XE05

ATC

[U] sorafenib

+∞

6.7

C68.9

ICD-10 Finland

Malignant neoplasm: Urinary organ, unspecified

+∞

6.7

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

6.7

316

Kela drug reimbursment

Imatinib

+∞

6.7

KDC00

NOMESCO Finland

Urethrectomy

+∞

6.7

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

6.7

C34

ICD-10 Finland

Malignant neoplasm of bronchus and lung

+∞

6.7

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

+∞

6.7

1502

Kela drug reimbursment

Cabozantinib

+∞

6.7

8120/3-C66.9

ICD-O-3

Transitional cell carcinoma, NOS, of ureter

+∞

6.7

C32.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of larynx

+∞

6.7

L01XE11

ATC

[U] pazopanib

+∞

6.7

JR2PR, ,

NOMESCO Finland

+∞

6.7

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

6.7

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

6.7

Z85.4

ICD-10 Finland

Personal history of malignant neoplasm of genital organs

+∞

6.7

3AX03, ,

NOMESCO Finland

+∞

6.7

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

6.7

8720/3-C69.9

ICD-O-3

Malignant melanoma, NOS, of eye, NOS

+∞

6.7

323

Kela drug reimbursment

Sorafenib

+∞

6.7

B82

ICPC

Anaemia other/unspecified

1.5

6.7

243

996

R06AE07

ATC

cetirizine; oral

1.1

6.7

3402

18544

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.1

6.7

2406

12847

E83.50

ICD-10 Finland

Hypercalcemia

2.1

6.7

199

JAB10

NOMESCO Finland

Repair of inguinal hernia

1.6

6.7

163

613

N32.1

ICD-10 Finland

Vesicointestinal fistula

2.7

6.7

K05.30

ICD-10 Finland

Periodontitis complex

1.2

6.7

1470

7581

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

0.3

6.7

391

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.3

6.7

531

2469

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.7

6.7

137

494

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.5

6.7

180

694

T90

ICPC

Diabetes non-insulin dependent

0.9

6.7

2805

18309

XX1VW

NOMESCO Finland

Written report from radiologist

2.1

6.6

184

KE1BE, ,

SPAT

3.2

6.6

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

53.5

6.6

C32.1

ICD-10 Finland

Malignant neoplasm: Supraglottis

53.5

6.6

UKB12

NOMESCO Finland

Retrograde endoscopy of cutaneous ureteroenterostomy

53.5

6.6

XKD10

NOMESCO Finland

Transurethral ultrasonography

53.5

6.6

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

53.5

6.6

R50.8

ICD-10 Finland

Other specified fever

2.6

6.6

OAB42, ,

SPAT

0.8

6.6

634

4662

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.5

6.6

202

801

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

2.1

6.6

177

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.3

6.5

394

1763

A60

ICPC

General and Unspecified, Result test/procedure

1.4

6.5

320

1386

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.6

6.5

151

1386

E34.0

ICD-10 Finland

Carcinoid syndrome

11.0

6.5

I71.3

ICD-10 Finland

Abdominal aortic aneurysm, ruptured

0.5

6.5

589

L04AB04

ATC

adalimumab; parenteral

0.4

6.4

522

F20.8

ICD-10 Finland

Other schizophrenia

0.0

6.4

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.2

6.4

690

3327

SPAT1283

SPAT

Restricted health certificate

0.8

6.4

458

3487

188

Kela drug reimbursment

Psychosis requiring demanding treatment

0.2

6.4

289

WW409

NOMESCO Finland

Other aferesis

16.4

6.4

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

2.0

6.4

224

E66.8

ICD-10 Finland

Other obesity

0.7

6.4

165

1479

WX140

NOMESCO Finland

Parabulbar anesthesy

1.3

6.3

481

2224

L72.1

ICD-10 Finland

Trichilemmal cyst

1.3

6.3

573

2709

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

1.9

6.3

241

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

0.7

6.3

286

2322

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.0

6.3

196

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

2.3

6.3

122

A10BJ06

ATC

semaglutide; parenteral

0.7

6.3

321

2560

ZZA00

NOMESCO Finland

Split skin graft

1.5

6.3

231

951

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

1.6

6.3

141

521

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.7

6.3

129

466

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

6.3

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

0.7

6.2

231

1938

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

2.4

6.2

108

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

1.9

6.2

272

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

11.9

6.2

R30.0

ICD-10 Finland

Dysuria

1.4

6.1

281

1204

WPA15, ,

SPAT

19.8

6.1

V03AF03

ATC

calcium folinate; systemic

19.8

6.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.4

6.1

302

1310

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

4.0

6.1

JGA35

NOMESCO Finland

Other endoscopic haemostatic procedure in rectum

9.7

6.1

ZZS00

NOMESCO Finland

Rotation flap

8.3

6.1

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

2.0

6.1

211

Z00.0

ICD-10 Finland

General medical examination

1.1

6.1

1894

10017

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

2.2

6.1

155

NHQ40

NOMESCO Finland

Amputation of toe

0.6

6.1

114

1096

F20

ICD-10 Finland

Schizophrenia

0.2

6.0

201

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.6

6.0

142

531

Z43.3

ICD-10 Finland

Attention to colostomy

4.8

6.0

H36.01

ICD-10 Finland

Diabetic maculopathy

0.5

6.0

605

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7790

31702

1.97

321.25

7.5

4.2

11.68

13.44

umol/l

30.71

7492

29910

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1577

3126

3.24

318.91

3.9

1.5

23.68

2.71

ug/l

3.68

1301

2343

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

546

405

8.28

313.64

2.4

1.3

23.56

17.56

ug/l

1.16

534

393

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3504

10669

2.25

309.75

3.8

2.7

0.58

0.77

e6/l

3.28

2186

5995

(4035726) Immunohistochemistry procedure

1549

1684

5.99

307.65

1.3

—

(3018095) Leukocytes [#/volume] in Urine

6640

22637

2.35

307.65

4.5

3.5

73.77

95.83

e6/l

1.09

5449

16698

(3000850) Epithelial cells [#/volume] in Urine

4557

13890

2.37

307.65

2.9

2.5

2.50

2.72

e6/l

0.93

4170

12402

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10393

43855

2.37

307.65

7.9

3.7

15.37

24.15

307.65

7498

20552

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12530

54882

3.31

307.65

11.6

3.8

9.72

1.97

ug/l

26.75

11268

49503

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8203

30781

2.31

307.65

4.8

2.7

1.05

0.69

ug/l

49.79

6591

20524

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7370

28199

2.10

307.65

2.7

2.4

—

(40768800) Prostate Pathology biopsy report

4278

713

49.72

307.65

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4050

8198

3.66

307.65

2.2

8.37

14.96

nmol/l

313.47

3494

7340

(3002256) Pathology report gross observation

2329

4717

3.29

307.65

1.4

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

6372

20244

2.53

307.65

4.1

3.1

139.64

110.14

e6/l

0.42

5290

15684

(3026008) Bacteria identified in Urine by Culture

4826

14262

2.50

307.65

3.4

2.7

—

(3026782) Osmolality of Urine

4228

13211

2.26

307.65

3.4

2.7

600.79

585.70

mosm/kgh2o

4.23

3756

11208

(3030467) Casts [#/volume] in Urine by Automated count

5724

18360

2.39

307.65

3.9

3.0

0.29

0.47

e6/l

7.68

4688

14011

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

7360

24241

2.60

307.65

3.9

3.1

—

0.67

—

(40768804) Tissue Pathology biopsy report

5893

17247

2.71

307.65

2.3

1.6

—

(36304419) Bacteria [Presence] in Urine

5412

17445

2.33

307.65

3.8

2.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

10663

39143

3.21

307.65

5.1

3.7

304.91

606.07

e6/l

0.68

213

746

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11339

48808

2.62

307.65

9.5

5.6

81.74

75.29

u/l

18.20

10946

45417

(3037467) Urinalysis macro (dipstick) panel - Urine

9978

43346

2.13

307.65

4.7

3.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4937

17599

2.00

287.64

4.4

2.1

2.34

2.33

mmol/l

6.22

4449

14905

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3579

11521

2.12

270.94

3.5

2.6

0.76

0.89

e6/l

2.49

2243

6802

(3049717) Cytology report of Urine Cyto stain

1348

2931

2.91

231.20

3.0

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

4865

18467

1.84

222.38

2.6

2.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7069

30928

1.69

188.66

7.9

6.6

1.20

mmol/l

3.02

5927

26338

(3013650) Neutrophils [#/volume] in Blood by Automated count

7464

33659

1.64

170.81

9.2

6.3

4.31

4.52

e9/l

8.26

6514

28826

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6475

28194

1.65

169.57

6.8

6.3

1.20

mmol/l

5.50

5902

25468

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3735

14289

1.74

155.05

2.6

2.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

6113

26670

1.62

153.98

5.0

4.2

34.70

35.19

g/l

7.75

5654

24513

(3013826) Glucose [Moles/volume] in Serum or Plasma

8534

40890

1.57

138.74

4.9

5.0

6.86

7.04

mmol/l

10.28

8117

38438

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1418

4027

2.21

138.44

3.5

2.6

0.18

0.29

e6/l

3.29

1398

3965

(3003694) ABO and Rh group [Type] in Blood

3999

16098

1.65

134.18

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

6709

30911

1.53

124.26

3.8

3.3

0.00

estimate

2.50

1485

4924

(3022217) INR in Platelet poor plasma by Coagulation assay

7528

35574

1.52

123.86

17.1

19.3

1.35

1.41

inr

5.72

2328

9754

(3021601) Nitrite [Presence] in Urine by Test strip

6620

30481

1.53

122.28

5.0

4.3

0.00

estimate

0.50

1557

5365

(3035350) Ketones [Presence] in Urine by Test strip

6635

30774

1.51

116.36

3.8

3.2

0.00

estimate

0.35

1623

5681

(3041096) Erythrocytes [Presence] in Urine by Automated

3839

15813

1.60

113.99

3.5

3.0

—

(3018418) pH of Serum or Plasma

4107

17375

1.56

107.63

5.1

3.7

7.40

1.11

905

3200

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2028

7200

1.78

103.68

4.6

2.7

250.93

240.73

u/l

1.51

1932

6684

(3023368) Bacteria identified in Blood by Culture

4576

20129

1.51

98.47

4.6

4.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2544

9796

1.66

96.60

3.5

2.0

2.46

2.43

mmol/l

17.06

2241

8267

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11711

62400

1.55

92.57

19.1

13.2

75.59

76.94

ml/min/173m2

11.14

10319

51059

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12058

64689

1.58

92.30

17.8

14.2

29.76

27.11

mg/l

10.93

10079

51527

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5261

24050

1.47

92.05

4.1

3.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

535

1179

2.76

87.85

3.0

2.0

934.34

19.93

u/ml

2.35

452

971

(40758558) Short blood count panel - Blood

3369

14267

1.52

84.07

7.3

4.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

12755

69953

1.60

78.26

21.0

17.4

139.57

139.76

mmol/l

13.92

12492

68124

(3029937) Albumin [Presence] in Urine by Test strip

3876

17161

1.46

76.58

4.1

3.6

0.00

estimate

0.13

1410

4922

(3023103) Potassium [Moles/volume] in Serum or Plasma

12770

70157

1.59

75.88

21.2

17.5

4.02

4.03

mmol/l

4.95

12491

68253

(40761536) Microorganisms panel - Urine sediment

1399

4879

1.78

74.34

3.9

3.7

—

(3033658) Prothrombin time (PT) actual/Normal

3612

15947

1.46

71.50

4.1

4.0

85.21

81.56

14.38

3549

15566

(3013512) EKG study

4610

21303

1.42

71.24

4.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1801

6958

1.61

65.16

3.6

3.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12766

70652

1.53

64.14

23.5

16.6

90.76

89.60

umol/l

2.46

12761

70620

(40761511) CBC panel - Blood by Automated count

12267

67545

1.46

59.75

18.3

13.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

5941

29267

1.34

58.77

5.7

5.8

24.73

25.85

10.67

5531

27236

(3015736) pH of Urine

5125

24729

1.35

57.79

3.5

3.0

5.67

0.00

253

1407

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3618

16519

1.40

57.21

2.1

2.2

2.99

2.91

mg/l

1.14

3053

13961

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1307

4805

1.68

56.94

5.0

3.5

1.22

1.21

mmol/l

0.89

1139

4138

(3019069) Monocytes/100 leukocytes in Blood

5802

28581

1.34

56.77

5.8

6.0

9.18

9.11

0.82

5385

26513

(3006504) Eosinophils/100 leukocytes in Blood

5764

28421

1.34

55.69

5.5

5.7

2.97

3.05

1.44

5343

26335

(3019225) pH of Specimen

1575

6149

1.58

53.90

4.9

3.8

—

(3022096) Basophils/100 leukocytes in Blood

5581

27544

1.33

52.64

5.5

5.7

0.62

0.66

5.92

5173

25507

(3018010) Neutrophils/100 leukocytes in Blood

5810

28858

1.32

52.31

5.5

5.6

59.41

58.57

5.23

5408

26862

(3021589) Normoblasts [#/volume] in Blood

5617

27777

1.32

52.08

11.8

8.9

0.00

e9/l

0.23

4701

22852

(40768795) Lymph node Pathology biopsy report

101

6.86

51.41

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

5714

28496

1.31

48.92

6.0

5.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12585

70301

1.42

46.86

12.1

9.3

27.05

28.90

u/l

9.76

12113

67392

(3009542) Hematocrit [Volume Fraction] of Blood

12914

72494

1.46

46.67

27.9

20.8

40.00

41.56

23.78

12094

66837

(3007461) Platelets [#/volume] in Blood

12915

72533

1.45

46.04

27.8

20.5

230.02

228.48

e9/l

1.98

12646

70176

(3035941) MCH [Entitic mass]

12916

72557

1.45

45.71

27.7

20.4

30.67

30.73

2.65

12768

71191

(3010813) Leukocytes [#/volume] in Blood

12918

72574

1.45

45.64

27.8

20.5

6.82

6.91

e9/l

3.36

12605

69906

(3024731) MCV [Entitic volume]

12918

72574

1.45

45.64

27.7

20.4

91.86

91.70

3.55

12772

71200

(3026361) Erythrocytes [#/volume] in Blood

12918

72575

1.45

45.62

27.8

20.5

4.46

4.61

e12/l

168.89

12598

69903

(3000963) Hemoglobin [Mass/volume] in Blood

12919

72585

1.45

45.55

28.0

20.6

135.50

140.87

g/l

232.73

12762

71217

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4691

22952

1.31

45.03

2.7

2.9

239.79

183.31

ug/l

11.18

4191

20995

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

295

678

2.62

44.79

2.9

1.9

143.22

23.48

u/ml

1.14

269

606

(3022145) Colonoscopy Study observation

1564

6415

1.50

42.30

1.4

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2272

10012

1.41

42.29

3.2

2.9

0.82

mmol/l

1.80

2150

9274

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

263

598

2.64

40.79

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

13.82

39.83

7.8

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

588

1915

1.86

38.37

4.3

3.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1053

4053

1.59

37.70

7.7

11.6

—

(3019198) Lymphocytes [#/volume] in Blood

6121

31497

1.26

37.60

5.4

5.5

1.74

1.81

e9/l

2.15

5324

27538

(3001604) Monocytes [#/volume] in Blood

5958

30625

1.26

36.59

5.3

5.4

0.64

0.65

e9/l

2.09

5060

26249

(3017181) Myelocytes/100 leukocytes in Blood

1248

5033

1.52

36.30

3.4

3.7

1.12

0.81

3.47

482

1475

(3006315) Basophils [#/volume] in Blood

5974

30741

1.26

36.22

5.3

5.4

0.04

e9/l

13.20

5077

26348

(3013115) Eosinophils [#/volume] in Blood

6143

31734

1.26

35.92

5.5

5.6

0.20

0.22

e9/l

7.02

5280

27508

(40761535) Cells panel - Urine sediment

1425

5948

1.47

35.01

3.5

3.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1518

6447

1.44

34.05

2.9

2.4

8.57

9.27

umol/l

0.65

1352

5716

(3002385) Erythrocyte distribution width [Ratio]

10062

55225

1.26

33.12

22.6

16.2

15.28

15.33

0.30

9942

54065

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4084

20241

1.27

33.06

2.6

2.4

59.70

63.05

u/l

1.32

3760

18647

(3021440) Promyelocytes/100 leukocytes in Blood

1182

4821

1.50

32.46

3.4

3.7

0.12

0.07

1.57

423

1275

(3027945) Reticulocytes/100 erythrocytes in Blood

1894

8476

1.38

31.37

2.5

2.1

1.75

1.73

0.34

1646

7410

(3002179) Metamyelocytes/100 leukocytes in Blood

1126

4585

1.50

31.13

3.4

3.5

0.97

0.61

2.44

417

1288

(3000330) Specific gravity of Urine by Test strip

894

3478

1.56

30.44

4.0

3.0

—

(3044889) 12 lead EKG panel

8994

48957

1.23

30.24

4.3

4.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

8666

47004

1.23

30.02

3.8

3.9

14.14

11.47

mm/h

33.50

7835

43249

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1210

5035

1.47

30.01

2.2

2.1

0.21

0.20

g/l

1.02

1114

4538

(3025159) Blasts/100 leukocytes in Blood

1114

4564

1.49

29.86

3.4

3.8

0.05

0.07

0.35

367

1043

(3023520) Reticulocytes [#/volume] in Blood

1464

6326

1.42

29.68

2.6

2.2

67.83

68.11

e9/l

0.12

1138

4841

(3021960) Folate [Moles/volume] in Serum or Plasma

3313

16203

1.28

29.16

1.6

18.35

18.88

nmol/l

1.25

2814

13943

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4019

20155

1.25

28.57

3.5

2.8

35.28

37.50

u/l

0.75

3782

18940

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

5.47

28.20

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

297

847

2.11

28.16

3.2

2.9

1.90

1.44

1.00

250

723

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2415

11386

1.31

27.98

1.9

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2175

10228

1.31

25.44

2.5

2.8

2.19

2.24

g/l

2.68

1987

9438

(3022948) Iron [Moles/volume] in Serum or Plasma

2317

10997

1.30

25.29

2.5

2.7

12.53

13.26

umol/l

4.76

2136

10204

(3022621) pH of Urine by Test strip

996

4129

1.46

25.07

2.9

2.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

964

3993

1.46

24.36

8.3

10.8

23.75

24.25

mmol/l

5.23

939

3814

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2062

9683

1.31

24.26

2.6

2.9

22.87

23.80

2.01

1710

8199

(3045414) Leukocytes [Presence] in Urine

684

2663

1.55

23.17

2.1

1.7

—

(3016502) Oxygen saturation in Arterial blood

1788

8290

1.32

22.96

6.8

8.4

95.74

94.92

5.81

1691

8001

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1620

7405

1.34

22.95

7.2

9.0

121.72

125.25

g/l

9.12

1554

7238

(3014111) Lactate [Moles/volume] in Serum or Plasma

1444

6545

1.34

21.58

6.7

8.0

1.37

1.46

mmol/l

1.52

1401

6361

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

757

3073

1.49

21.13

2.0

3.69

2.10

ug/l

1.16

656

2724

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

4.12

20.86

5.9

1.1

36.92

140.51

u/ml

0.49

(3003396) Base excess in Arterial blood by calculation

1908

9065

1.29

20.29

6.6

8.0

0.46

1.10

mmol/l

9.64

1493

7149

(3027801) Oxygen [Partial pressure] in Arterial blood

1904

9051

1.29

20.15

6.6

8.0

12.31

11.40

kpa

11.87

1790

8635

(3045142) Bone marrow Pathology biopsy report

173

455

2.27

20.07

1.3

1.2

—

(3000012) Reticulocyte production index

321

1062

1.81

20.07

2.2

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

989

4266

1.40

20.02

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1903

9058

1.29

19.92

6.6

8.0

5.09

5.04

kpa

1.28

1789

8644

(3019150) Specific gravity of Urine by Refractometry

2831

14151

1.23

19.43

4.3

3.6

1.02

kg/l

0.52

452

2057

(3042111) Morphology [Interpretation] in Bone marrow Narrative

261

818

1.91

19.28

1.5

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

430

1577

1.64

18.71

2.9

2.2

—

(21494755) Public health laboratory ask at order entry panel

502

4482

0.65

18.28

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1861

8934

1.27

18.08

6.1

6.7

1.03

mmol/l

0.36

1729

8332

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

967

4238

1.38

17.80

6.2

8.6

24.35

24.61

mmol/l

1.34

959

4190

(3000991) Gas panel - Venous blood

1358

6268

1.32

17.79

8.1

9.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

684

2835

1.45

17.21

2.0

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2928

14883

1.21

16.71

3.8

3.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

233

742

1.88

16.49

1.5

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1274

5906

1.31

16.13

2.7

1.7

65.89

66.97

g/l

5.36

1158

5368

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

100

225

2.65

16.12

1.5

1.3

4.16

4.19

mg/l

0.02

217

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1237

5713

1.31

16.09

3.1

2.5

65.08

62.47

ml/min/173m2

1.37

508

2115

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4421

23382

1.18

16.03

3.0

3.2

1832.86

1692.09

ng/l

0.84

3804

20271

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

15.99

1.1

0.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

628

2603

1.45

15.81

1.9

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5396

29028

1.16

15.71

3.9

51.36

88.59

ng/l

3.66

4365

22289

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

931

4156

1.35

15.26

1.8

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1124

5175

1.31

14.93

2.3

2.4

35.82

43.20

u/l

0.99

942

4398

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2333

11713

1.22

14.90

2.0

2.1

30.27

30.41

0.51

2269

11368

(3017354) Segmented neutrophils/100 leukocytes in Blood

185

565

1.96

14.84

3.2

3.0

58.04

61.93

1.29

143

467

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1817

8899

1.24

14.68

4.7

4.9

31.51

31.48

0.04

1193

6278

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4112

21775

1.17

14.32

2.0

2.1

78.38

75.44

nmol/l

8.30

3560

19167

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

615

2591

1.43

14.22

2.8

3.2

0.36

0.33

u/ml

1.17

343

1545

(3008757) Leukocyte morphology finding [Identifier] in Blood

197

626

1.88

14.11

3.8

3.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

166

506

1.96

13.44

1.5

1.2

101.41

54.80

u/l

2.52

146

444

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5356

29057

1.15

13.21

2.0

93.60

91.66

pmol/l

2.30

3074

16674

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1057

4925

1.30

12.85

8.5

10.5

0.57

0.68

16.33

1048

4889

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

209

699

1.79

12.79

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1134

8389

0.79

12.43

1.8

1.9

1.66

1.62

0.53

937

7185

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11474

65738

1.16

12.30

5.0

6.14

6.22

mmol/l

8.76

10158

59813

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

108

289

2.23

12.24

1.3

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

789

3558

1.34

12.11

1.5

1.6

1.61

1.52

g/l

1.93

673

3026

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1054

4954

1.28

11.98

8.4

10.3

1.22

1.43

7.76

1046

4915

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

373

1481

1.51

11.71

1.4

—

(3045424) Erythrocytes [Presence] in Urine

271

1004

1.62

11.50

1.4

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

143

438

1.95

11.50

1.6

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

719

3234

1.34

11.25

4.1

5.2

0.87

0.88

0.05

655

3059

(3012501) Base excess in Blood by calculation

415

1699

1.46

11.24

4.0

4.7

2.16

2.44

mmol/l

1.30

265

1133

(3013290) Carbon dioxide [Partial pressure] in Blood

415

1700

1.46

11.21

4.0

4.7

4.90

4.98

kpa

1.23

406

1653

(3037756) Immunofixation for Serum or Plasma

358

1426

1.50

11.10

1.6

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

416

1710

1.46

11.04

4.0

4.7

8.42

8.35

kpa

0.29

407

1662

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

729

3299

1.33

10.95

4.1

5.1

1.58

1.72

3.44

662

3124

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

10.94

1.0

0.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9991

56863

1.14

10.74

3.7

2.47

2.14

mu/l

0.50

8711

51080

(3020779) Urea [Moles/volume] in Serum or Plasma

1468

7268

1.22

10.57

6.9

8.1

11.35

11.26

mmol/l

0.16

1394

6883

(40765096) Chromosome analysis panel by Banding

3.07

10.36

1.2

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1589

7948

1.21

10.32

1.8

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

224

2.26

10.06

2.8

2.9

—

(3010421) pH of Blood

455

1937

1.41

10.03

3.9

4.7

7.42

0.45

428

1736

(40768443) Skin Pathology biopsy report

553

2434

1.36

10.00

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1049

5046

1.25

9.85

2.2

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

390

1626

1.44

9.67

2.4

2.7

15.97

16.90

3.63

216

888

(3019309) Folate [Moles/volume] in Red Blood Cells

2640

13867

1.16

9.63

1.8

1130.24

nmol/l

0.00

1938

10591

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

517

2267

1.37

9.58

2.8

1.6

3.52

2.55

ratio

0.34

181

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

277

1080

1.53

9.55

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

363

1501

1.45

9.41

1.5

—

(3010503) CD19 cells [#/volume] in Blood

243

2.16

9.37

2.7

2.3

0.09

0.14

e9/l

2.58

236

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1087

5281

1.24

9.35

3.6

5.09

5.11

kpa

0.34

1015

4990

(3009343) pH of Capillary blood

1073

5206

1.24

9.34

3.6

7.41

0.06

151

632

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1040

5034

1.24

9.25

3.5

3.6

1.53

1.56

mmol/l

0.09

742

3628

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

750

3493

1.29

9.19

2.5

2.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

203

2.26

9.15

1.9

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

526

2331

1.35

9.14

2.9

1.6

73.41

37.91

mg/l

0.75

411

1865

(3034860) Kappa light chains.free [Mass/volume] in Serum

526

2335

1.35

9.04

2.9

1.6

66.06

53.15

mg/l

0.64

408

1870

(1616796) Gas panel - Central venous blood

409

1742

1.41

9.04

3.8

4.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

256

2.10

8.93

1.2

1.1

18.29

28.74

u/l

1.47

225

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

293

2.01

8.86

1.9

1.5

6.62

8.22

u/l

0.57

240

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

273

2.05

8.85

1.7

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

349

1451

1.44

8.82

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

274

2.05

8.77

1.7

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1576

7997

1.19

8.73

1.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

256

2.07

8.60

1.2

1.1

67.03

93.82

u/l

3.10

229

(3018572) Chloride [Moles/volume] in Blood

401

1718

1.40

8.59

5.2

7.2

104.98

105.05

mmol/l

0.11

344

1577

(3039000) Anion gap in Blood

401

1718

1.40

8.59

5.2

7.2

11.07

11.51

mmol/l

1.86

344

1577

(3017732) Neutrophils [#/volume] in Blood

847

4041

1.26

8.56

2.7

3.0

4.80

5.64

e9/l

1.08

647

3104

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

202

2.21

8.52

1.9

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

337

0.19

8.46

17.4

15.8

1498.55

1352.48

nmol/l

0.33

323

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.88

8.44

1.9

2.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.18

8.43

1.2

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

203

2.20

8.42

1.9

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

322

0.18

8.29

13.0

11.6

1015.30

809.34

nmol/l

—

306

(3047181) Lactate [Moles/volume] in Blood

538

2430

1.33

8.27

4.8

6.3

1.34

1.38

mmol/l

0.46

453

2192

(3052851) Hemolysis interference index of Serum or Plasma

449

1975

1.36

8.22

3.6

3.4

—

(3011412) CD3 cells [#/volume] in Blood

111

352

1.88

8.21

2.6

2.2

1.02

1.05

e9/l

0.08

101

324

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

450

3552

0.75

8.13

1.6

1.8

44.70

43.54

nmol/l

0.50

435

3425

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7417

41816

1.11

8.12

3.2

3.1

57.32

57.33

u/l

0.00

6757

38520

(3028626) Oxygen [Partial pressure] in Capillary blood

415

1807

1.38

8.10

2.7

3.0

7.83

7.87

kpa

0.18

401

1771

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

849

4079

1.25

8.09

1.6

1.5

—

(40768441) Liver Pathology biopsy report

181

2.24

7.96

1.4

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

398

1727

1.38

7.94

2.8

1.5

—

(40758292) HTLV I+II Ab panel - Serum

3.62

7.61

1.4

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

5.62

7.46

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11120

64168

1.12

7.46

6.3

6.7

40.58

41.34

mmol/mol

12.25

10044

59370

(1175426) CD3 cells/100 lymphocytes in Blood

251

1.99

7.40

1.7

2.2

66.36

71.23

2.05

236

(21494814) CD8 cells/100 lymphocytes in Specimen

138

2.37

7.37

1.7

2.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

537

2469

1.30

7.32

2.5

2.9

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

11.90

7.16

10.0

1.0

0.27

—

umol/l

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

335

1443

1.39

7.04

1.7

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

281

1181

1.42

6.81

1.8

2.0

1.90

1.80

mmol/l

0.57

271

1151

(3021901) Oxygen saturation in Capillary blood

361

1584

1.36

6.79

2.6

2.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

6.73

1.0

0.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

671

3211

1.25

6.67

3.8

3.9

24.54

24.63

mmol/l

0.35

612

2958

(40768797) Stomach Pathology biopsy report

1583

8220

1.16

6.60

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

241

2024

0.70

6.53

1.4

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

736

3571

1.24

6.48

4.0

4.5

23.74

23.93

mmol/l

0.91

726

3468

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

170

652

1.56

6.46

1.4

461.94

469.50

u/l

0.02

160

611

(3009466) Valproate [Moles/volume] in Serum or Plasma

115

1119

0.61

6.42

3.4

4.7

334.83

349.53

umol/l

0.50

938

(40761539) Cells [Type] in Urine sediment by Light microscopy

156

2.18

6.34

1.1

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

875

4335

1.21

6.30

2.5

1.8

370.35

357.72

nmol/l

0.85

814

3937

(3003434) Protein [Mass/volume] in Pleural fluid

238

989

1.44

6.17

1.5

32.22

30.44

g/l

1.20

197

875

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

181

712

1.52

6.16

1.5

1.7

—

(3012544) pH of Venous blood

1490

7743

1.16

6.15

3.9

4.1

7.38

7.37

0.22

(3002032) Base excess in Venous blood by calculation

1424

7375

1.16

6.14

3.9

4.1

1.60

1.74

mmol/l

0.64

1194

6221

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

227

1.94

6.14

1.8

2.2

—

(40768806) Pleura Pathology biopsy report

184

727

1.51

6.14

1.6

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11728

68077

1.11

6.13

5.3

5.5

2.56

2.53

mmol/l

3.72

10468

62997

(3043410) Blood group antigens tested for on Red Blood Cells

159

2.13

6.07

2.0

1.6

—

(4034850) Laboratory test

313

2489

0.74

6.05

13.5

10.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

173

677

1.52

6.04

2.4

2.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.31

6.04

1.0

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

139

518

1.60

6.00

1.3

14.62

13.57

u/l

0.14

126

480

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

5.89

1.0

0.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

174

686

1.51

5.89

1.4

1.3

—

(3012441) Differential panel - Pleural fluid

191

768

1.48

5.88

1.4

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

402

1836

1.31

5.84

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

169

668

1.51

5.67

1.4

6.10

6.55

mmol/l

1.15

145

609

(21494434) Karyotype in Bone marrow

134

504

1.59

5.60

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

206

850

1.45

5.59

1.8

2.3

23.08

27.72

mg/l

0.45

238

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

111

2.31

5.51

1.7

2.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1416

7391

1.15

5.51

3.9

4.1

5.76

5.83

kpa

2.09

1387

7170

(3045788) Cell count panel - Pleural fluid

168

669

1.50

5.46

1.4

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

108

2.31

5.44

2.0

1.4

47.32

35.04

u/l

0.19

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

108

388

1.66

5.42

1.4

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

240

0.25

5.37

2.2

2.7

131.50

138.98

nmol/l

—

209

(3005988) Vibrio sp identified in Specimen by Organism specific culture

170

681

1.49

5.37

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

170

681

1.49

5.37

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

176

711

1.48

5.34

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

104

373

1.66

5.27

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

134

512

1.56

5.26

1.4

12.24

13.53

u/l

1.58

129

491

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

396

1.64

5.26

1.4

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

231

987

1.40

5.21

1.5

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

231

987

1.40

5.21

1.5

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

298

2331

0.75

5.19

1.2

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

285

1.76

5.18

1.8

1.2

101.57

102.27

u/l

0.01

239

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

171

692

1.47

5.16

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

273

2160

0.75

5.16

1.2

1.4

—

(3022313) Gas panel - Capillary blood

766

3829

1.20

5.08

3.9

3.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

168

680

1.47

5.07

1.4

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

+∞

5.05

1.2

0.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

458

2172

1.26

5.02

1.9

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

137

533

1.53

5.00

1.8

1.9

2.23

1.39

u/field

0.70

222

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

136

529

1.53

4.97

1.5

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11459

66626

1.10

4.94

4.8

4.9

4.37

4.30

mmol/l

11.74

10308

61958

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

249

1089

1.36

4.91

3.3

59.05

59.50

0.20

249

1089

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

435

0.46

4.88

5.3

6.4

26.00

520.22

u/ml

—

102

(40768793) Breast Pathology biopsy report

3.30

4.87

1.1

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1193

8063

0.87

4.84

2.4

2.5

7.23

9.40

ug/l

2.88

1017

7202

(3005719) IgG [Mass/volume] in Serum or Plasma

787

3968

1.19

4.76

2.7

2.1

10.79

11.21

g/l

1.30

708

3600

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

361

1.63

4.75

1.7

1.8

2.91

2.50

u/field

0.21

260

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

227

1820

0.74

4.73

1.5

1.4

0.95

0.83

nmol/l

1.43

189

1497

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

134

530

1.51

4.57

1.6

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

134

530

1.51

4.57

1.6

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

134

530

1.51

4.57

1.6

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

486

2348

1.24

4.56

2.3

1.5

1.28

0.38

g/l

4.28

416

2026

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

261

1.73

4.55

3.0

2.0

576.08

445.84

e6/l

0.49

228

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

101

375

1.60

4.53

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

244

1.76

4.52

3.0

2.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

271

1.71

4.49

1.9

1.2

30.45

24.83

u/l

0.25

226

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1337

8914

0.88

4.42

1.2

31.69

48.43

iu/ml

2.06

377

2709

(3028308) Erythrocytes [#/volume] in Pleural fluid

188

801

1.40

4.38

1.4

1.5

60709.20

66821.47

e6/l

0.11

118

499

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

245

1090

1.34

4.38

4.6

7.1

5269.13

997.99

iu/ml

0.44

184

(3023199) Leukocytes [#/volume] in Pleural fluid

204

882

1.38

4.37

1.5

2137.67

4007.01

e6/l

0.82

147

651

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

345

2585

0.79

4.36

1.8

1.9

182.80

199.51

pmol/l

1.73

319

2437

(3020682) Albumin/Creatinine [Ratio] in Urine

4402

27636

0.92

4.32

3.8

4.0

8.65

9.26

mg/mmol

0.36

2892

19075

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

349

0.44

4.30

1.1

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11351

66086

1.09

4.29

4.7

4.9

1.34

1.29

mmol/l

25.54

10132

61017

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

570

2821

1.21

4.26

2.0

1.4

3.79

3.90

g/l

0.88

516

2534

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

2832

1.21

4.25

2.0

1.4

7.39

7.37

g/l

0.09

514

2545

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

2832

1.21

4.25

2.0

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

151

622

1.45

4.25

1.6

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

240

1.74

4.25

1.8

1.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

384

2831

0.80

4.22

1.5

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

242

1082

1.33

4.20

5.7

6.1

11.92

11.52

mg/l

0.64

227

995

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

471

0.53

4.12

2.2

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

451

2188

1.23

4.11

3.0

3.2

24.50

24.55

mmol/l

0.08

438

2145

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11021

64122

1.08

4.10

4.2

4.4

1.31

1.35

mmol/l

5.35

9736

58839

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

144

1.94

4.05

3.7

2.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

178

1.84

4.04

1.5

1.7

2580.20

16397.44

u/ml

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

672

4674

0.85

4.02

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

216

957

1.35

4.00

1.4

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

205

901

1.36

4.00

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

779

0.64

3.97

1.3

1.8

—

(3042936) Bacteria identified in Isolate by Culture

1890

10258

1.11

3.92

2.0

2.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

830

4279

1.16

3.89

4.1

4.9

106.24

110.11

ng/l

0.43

718

3730

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

113

448

1.50

3.88

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

321

1.60

3.84

2.8

2.1

539.82

642.25

e6/l

1.23

310

(3027944) Amphetamines [Presence] in Urine

758

0.64

3.84

1.3

1.8

—

(3042631) Mycobacterium sp identified in Specimen

219

980

1.33

3.82

2.3

2.8

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

274

0.41

3.81

17.4

13.4

0.63

0.67

mmol/l

0.39

246

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

1196

1.30

3.74

1.3

1.5

—

(3016879) Cocaine [Presence] in Urine

746

0.64

3.74

1.3

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

531

2650

1.20

3.68

2.0

1.4

10.40

10.41

g/l

0.02

466

2356

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

140

586

1.42

3.67

1.7

1.6

—

(3012516) Albumin [Mass/volume] in Urine

4176

26137

0.93

3.66

3.2

3.4

310.50

254.06

mg/l

0.43

2789

18308

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

158

1281

0.73

3.64

1.1

24.00

216.15

iu/ml

0.84

246

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2744

15209

1.09

3.64

1.8

1.7

24157197.32

32593171.05

pmol/l

0.40

2194

12558

(4094501) Cardiovascular stress test using bicycle ergometer

325

2397

0.80

3.64

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

284

1.61

3.63

1.2

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

284

1.61

3.63

1.2

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5531

31485

1.07

3.63

2.1

2.2

—

(3027008) Opiates [Presence] in Urine

783

0.66

3.61

1.3

1.8

—

(3028300) Cannabinoids [Presence] in Urine

783

0.66

3.61

1.3

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

346

2532

0.81

3.60

2.2

2.3

101.04

126.86

ug/min

0.48

190

1549

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

250

1.64

3.50

3.1

2.0

0.28

0.24

e9/l

0.44

226

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.33

3.49

2.9

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7449

42862

1.07

3.47

3.0

2.9

14.99

14.90

pmol/l

1.91

6492

38135

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

832

0.68

3.45

1.3

1.2

1.36

1.43

nmol/l

0.34

754

(3018834) Bilirubin.total [Presence] in Urine by Test strip

5.95

3.43

4.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

439

2169

1.21

3.41

2.7

2.9

0.32

0.37

g/l

0.60

203

973

(3028026) IgM [Mass/volume] in Serum or Plasma

618

3153

1.17

3.35

2.1

1.5

1.19

1.12

g/l

0.32

548

2868

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

300

1.57

3.34

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

300

1.57

3.34

1.5

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

4227

26368

0.93

3.31

3.1

3.4

8.37

8.59

mmol/l

2.64

3382

22257

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

184

828

1.32

3.16

2.2

3.0

574.07

11625.02

u/ml

0.49

(3038515) Glucose [Moles/volume] in Venous blood

354

1728

1.22

3.14

3.5

3.3

7.33

8.00

mmol/l

5.33

346

1691

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

371

0.54

3.14

1.1

2.1

—

(3004451) EKG impression Narrative

392

1.47

3.12

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

228

1060

1.28

3.10

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

367

1802

1.22

3.08

2.2

126.58

134.57

g/l

6.07

285

1328

(3048879) Bone marrow aspiration report

173

1.72

3.04

2.0

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

523

2658

1.18

3.01

2.1

1.4

3.00

2.92

g/l

1.03

468

2374

(3051611) Lipemic interference index of Serum or Plasma

155

686

1.35

3.00

3.1

3.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

333

1625

1.22

2.98

3.5

3.4

31.77

28.13

mg/l

1.02

213

1080

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

204

940

1.29

2.98

1.3

—

(3042733) HLA Ab [Presence] in Serum

317

0.52

2.95

5.2

5.3

—

(3051651) Icteric interference index of Serum or Plasma

363

1.48

2.94

3.6

4.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

193

1.67

2.94

1.3

130.17

3.15

ug/l

0.84

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

241

1789

0.80

2.94

1.5

1.6

25.34

3.88

iu/ml

0.50

404

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2406

13379

1.08

2.94

1.6

1.8

1.67

1.30

mg/l

3.17

1874

10511

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1251

8163

0.90

2.89

1.2

10.92

14.11

u/ml

0.81

417

3048

(3024354) Oxygen [Partial pressure] in Venous blood

1133

6092

1.11

2.85

3.1

3.3

4.54

4.61

kpa

0.41

1107

5871

(3007853) Bacteria identified in Skin by Aerobe culture

1470

8013

1.10

2.83

1.7

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

594

0.66

2.83

1.3

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

257

1885

0.81

2.82

1.1

1.2

0.21

0.65

u/ml

1.94

165

(3005322) IgE [Units/volume] in Serum or Plasma

446

3105

0.85

2.80

1.3

399.12

305.13

u/ml

0.60

415

2905

(3037522) Nuclear Ab [Titer] in Serum

1121

7343

0.90

2.79

1.2

1.3

427.76

468.26

titre

0.36

196

1433

(3008037) Lactate [Moles/volume] in Venous blood

367

1822

1.20

2.79

3.5

3.2

1.65

1.72

mmol/l

0.53

359

1777

(3036180) Methadone [Presence] in Urine

132

0.36

2.78

2.0

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

364

0.57

2.77

1.7

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

598

0.66

2.76

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

254

1858

0.81

2.73

1.4

1.8

3.51

4.18

mg/l

0.50

187

1349

(3035320) C reactive protein [Mass/volume] in Body fluid

414

1.42

2.72

2.5

2.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

257

1234

1.24

2.71

1.4

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

124

991

0.74

2.71

1.3

1.7

1.23

1.01

g/l

0.41

744

(3001019) Free T4 and TSH panel - Serum or Plasma

193

1452

0.79

2.68

1.5

—

(3025941) Bacteria identified in Stool by Culture

553

2854

1.16

2.66

1.3

—

(3006462) Nitrate [Presence] in Urine

313

1.48

2.65

4.1

2.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

115

497

1.38

2.63

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.62

2.61

6.2

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

674

0.69

2.59

1.1

3.48

1.86

iu/ml

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

214

1013

1.26

2.58

2.7

2.4

—

(3035285) Chloride [Moles/volume] in Venous blood

217

1030

1.26

2.56

2.6

2.4

105.86

105.87

mmol/l

0.02

212

1021

(3041354) Potassium [Moles/volume] in Venous blood

217

1030

1.26

2.56

2.6

2.4

4.12

4.13

mmol/l

0.20

212

1022

(3048689) Calprotectin [Mass/mass] in Stool

1012

5446

1.11

2.54

2.1

2.4

147.48

173.40

ug/g

1.15

790

4390

(3000475) Leukocytes [#/volume] in Synovial fluid

291

2080

0.83

2.51

1.6

21625.82

15570.21

e6/l

0.77

202

1545

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.82

2.50

1.7

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

197

1462

0.80

2.46

1.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

194

1.59

2.46

1.3

1.4

3.85

3.69

mmol/l

0.10

173

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

430

2195

1.17

2.42

2.1

1.5

37.09

37.49

g/l

0.66

375

1907

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

420

2142

1.17

2.40

2.2

1.5

0.06

0.02

g/l

0.81

387

1948

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

102

440

1.38

2.39

1.5

1.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

123

547

1.34

2.39

1.3

—

(3044941) Cell count panel - Synovial fluid

172

1289

0.79

2.36

1.4

—

(3022475) Manganese [Moles/volume] in Blood

4.62

2.35

1.9

1.6

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.97

2.31

1.2

1.7

1.60

0.82

u/field

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

702

0.73

2.22

1.0

671.70

734.52

ng/l

0.81

473

(3051101) Glucose [Moles/volume] in Cord blood

204

0.49

2.22

8.0

6.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

133

606

1.31

2.21

1.4

1.3

—

nmol/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

701

0.73

2.21

1.0

36.02

41.22

ng/l

0.73

481

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.18

2.20

1.6

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

700

0.73

2.19

1.0

274.50

305.57

ng/l

0.67

487

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.66

2.19

1.8

1.0

—

(3000494) Fungus identified in Specimen by Culture

1392

7667

1.09

2.18

1.4

1.5

—

(3002619) Bacteria identified in Specimen by Culture

122

1.71

2.16

1.2

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

566

0.70

2.14

1.1

1.2

71.43

146.56

titre

1.52

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

149

693

1.28

2.14

1.4

1.3

0.63

2.10

nmol/l

0.49

142

671

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

2.01

2.12

3.4

1.8

37.62

113.44

u/l

0.79

(3023323) Follitropin [Units/volume] in Serum or Plasma

305

1.42

2.09

1.7

1.3

12.06

9.92

iu/l

0.59

246

(3008898) HLA-B27 [Presence]

171

1262

0.80

2.09

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

149

696

1.27

2.08

1.4

1.3

0.14

0.24

nmol/l

0.75

(3014891) Appearance of Pleural fluid

115

1.71

2.06

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.98

2.05

1.0

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

275

1375

1.19

2.04

2.2

1.2

45.52

20.37

u/l

1.61

232

1179

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.46

2.02

11.2

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

440

0.67

2.02

1.1

2.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

235

0.56

2.01

7.0

7.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.90

2.00

3.3

1.5

—

(3012565) Volume of 24 hour Urine

338

1.39

2.00

2.1

1994.06

1997.06

0.01

288

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

386

1988

1.16

2.00

2.2

1.5

0.00

g/l

0.50

354

1797

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

199

968

1.22

1.97

4.5

4.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

379

1953

1.16

1.96

2.2

1.5

0.00

g/l

-0.00

351

1792

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

238

1687

0.84

1.96

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

376

2568

0.87

1.95

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

136

1019

0.79

1.93

1.3

1.4

127.85

178.79

pmol/l

3.95

136

1019

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

122

0.44

1.92

1.0

1.7

—

88.74

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

276

0.60

1.91

1.1

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

297

1505

1.18

1.91

1.4

1.3

—

(3003338) MCHC [Mass/volume]

9039

54666

0.96

1.90

24.7

18.4

333.45

334.51

g/l

18.86

8972

54171

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

297

1506

1.18

1.89

1.4

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

408

1.34

1.89

3.2

3.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

392

2660

0.87

1.86

4.7

4.9

3.91

3.97

mmol/l

1.67

385

2637

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3210

18296

1.05

1.84

1.7

1.36

1.38

mmol/l

0.66

2547

15036

(37021550) Renin [Units/volume] in Plasma --upright

124

1.63

1.83

1.4

1.2

81.66

52.69

mu/l

0.37

(3003181) Sodium [Moles/volume] in Urine

214

1059

1.20

1.81

1.3

60.68

65.81

mmol/l

1.11

175

835

(3019060) Gas panel - Arterial blood

1031

5657

1.09

1.81

4.4

5.1

—

(3009871) Measles virus Ab [Titer] in Serum

189

0.53

1.81

1.9

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

348

1795

1.16

1.80

2.0

2.5

3.76

3.63

g/l

0.72

328

1713

(3038071) Oxygen [Partial pressure] in Mixed venous blood

286

0.62

1.80

7.9

7.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

567

0.73

1.79

1.0

5.44

3.17

u/ml

0.28

252

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

654

0.75

1.77

1.1

6.59

8.57

au/ml

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

218

0.57

1.77

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

1.76

0.0

1.1

—

0.06

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

349

1805

1.15

1.75

1.9

2.3

88.38

85.64

1.66

336

1732

(3035880) pH of Pleural fluid

409

1.32

1.74

1.3

—

(3004775) Volume in Urine collected for unspecified duration

108

819

0.78

1.73

2.1

2.3

721.79

697.19

0.24

545

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.91

1.72

1.0

1.2

5.71

17.76

iu/ml

—

(40768446) Kidney Pathology biopsy report

333

0.66

1.72

2.0

1.7

—

(3000492) Spirometry study

981

6303

0.92

1.72

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

487

0.72

1.71

1.6

2.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

174

1.50

1.71

1.3

1.1

2.92

2.37

u/l

0.09

(1002224) Polysomnography panel

363

2459

0.87

1.71

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.72

1.70

1.5

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.58

1.68

1.0

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

967

5311

1.09

1.68

6.4

7.7

24.48

24.39

mmol/l

0.30

895

5108

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

161

1.51

1.65

1.4

15.47

28.43

2.63

129

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

659

0.77

1.63

1.1

—

(3019977) pH of Arterial blood

107

497

1.28

1.63

2.3

7.41

7.42

0.33

166

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

220

0.59

1.63

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

135

989

0.81

1.62

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.75

1.62

1.3

32.00

42.98

u/l

0.31

(3047189) Immunofixation for 24 hour Urine

286

1.37

1.61

2.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

135

0.48

1.61

2.0

2.3

—

155.88

—

(3008295) Osmolality of Serum or Plasma

118

556

1.26

1.61

1.3

1.4

279.49

280.39

mosm/kgh2o

0.12

421

(3024869) Neuronal Ab [Presence] in Serum

143

1.54

1.61

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

231

1.42

1.60

1.3

1.5

2.24

2.78

0.23

184

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

168

1201

0.83

1.58

1.1

3.29

9.05

u/ml

1.57

120

(40763590) HLA-DQ beta [Type]

3.24

1.58

1.0

—

(4200892) Spirometry reversibility

799

5155

0.92

1.57

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.70

1.53

2.1

2.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

309

1603

1.15

1.53

2.2

2.6

208.78

199.64

0.97

295

1519

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

269

1.37

1.52

1.4

65.06

65.95

0.07

210

(4062490) Immunoglobulin typing, IgG

611

0.77

1.52

1.1

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

323

0.68

1.51

7.9

7.7

—

(3014271) Vancomycin [Susceptibility]

430

1.29

1.49

2.7

2.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

255

1.38

1.49

2.4

2.7

28.62

39.85

4.61

118

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

681

3707

1.10

1.48

2.8

2.9

0.64

0.65

0.51

675

3694

(3014133) Dog dander IgE Ab [Units/volume] in Serum

405

0.72

1.48

1.0

1.1

1.24

2.92

u/ml

1.16

193

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.68

1.48

2.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

699

3811

1.09

1.47

2.8

2.9

1.26

1.28

0.14

692

3793

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

493

0.75

1.46

1.1

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

249

1709

0.86

1.46

1.8

1.9

10.47

11.44

mg/l

1.16

226

1601

(40760410) HLA-B [Type] by High resolution

2.97

1.45

1.0

—

(40760409) HLA-A [Type] by High resolution

2.97

1.45

1.0

—

(3013862) HLA-DP [Type]

2.97

1.45

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.97

1.45

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1262

7051

1.07

1.44

2.7

3.2

227.05

255.70

ng/l

1.25

1147

6475

(3023430) Cat dander IgE Ab [Units/volume] in Serum

375

0.71

1.43

1.0

0.26

2.91

u/ml

3.71

144

(3027135) IgG subclass 1 [Mass/volume] in Serum

612

0.78

1.43

1.1

1.4

7.29

6.93

g/l

0.34

422

(3028192) IgG subclass 2 [Mass/volume] in Serum

611

0.78

1.41

1.1

1.4

3.45

3.20

g/l

0.53

424

(3024139) IgG subclass 3 [Mass/volume] in Serum

611

0.78

1.41

1.1

1.4

0.50

0.45

g/l

0.54

426

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.84

1.40

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.84

1.40

1.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.84

1.40

1.4

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

110

1.57

1.39

1.4

1.5

9.60

8.43

0.14

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

434

0.74

1.38

1.9

2.0

16.28

15.07

nmol/l

0.61

397

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

186

1298

0.85

1.37

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

548

0.77

1.37

1.0

0.51

0.92

u/ml

0.47

210

(3000093) Morphology [Interpretation] in Blood Narrative

139

682

1.21

1.36

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

487

0.76

1.36

1.2

1.3

1.31

1.25

nmol/l

0.12

358

(3048929) Epstein Barr virus Ab [Presence] in Serum

236

1213

1.16

1.36

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.62

1.36

1.3

22.07

28.74

0.39

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

237

0.65

1.34

1.1

—

8.11

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

151

750

1.20

1.32

3.2

3.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2572

14706

1.05

1.31

3.9

4.2

787.90

826.36

ng/l

0.04

2224

12720

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

129

632

1.21

1.30

1.4

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.11

1.30

3.5

1.5

—

(3003129) Base excess in Capillary blood by calculation

242

1.35

1.28

1.7

1.5

0.36

0.33

mmol/l

0.02

230

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.97

1.27

1.2

3.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.97

1.27

2.4

7.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

222

1.37

1.27

1.4

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

212

0.64

1.27

1.2

1.7

11.02

13.15

g/l

0.56

157

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.58

1.26

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

373

1.28

1.25

1.6

1.4

3.53

4.22

0.25

(3017704) Immunofixation for Urine

416

1.26

1.24

1.4

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

906

5036

1.07

1.23

3.4

3.5

127.39

132.78

g/l

9.06

885

4919

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

638

0.80

1.23

1.0

1.1

0.65

1.48

u/ml

1.63

330

(3020191) Ethanol [Moles/volume] in Serum or Plasma

100

728

0.82

1.21

1.2

1.4

1.23

1.50

promille

1.05

560

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

412

2701

0.90

1.20

1.7

1.8

38.27

37.56

u/l

0.27

354

2298

(3040151) Glucose [Moles/volume] in Capillary blood

190

972

1.16

1.20

5.9

14.5

7.13

7.69

mmol/l

2.02

158

791

(3024932) HLA-DR beta [Type]

272

0.70

1.19

1.2

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.16

1.18

1.4

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

306

0.72

1.18

1.2

1.1

1.09

ratio

0.02

(3013166) Neutrophils/100 leukocytes in Synovial fluid

305

0.72

1.16

1.2

1.3

64.31

60.60

0.28

270

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

259

1737

0.88

1.15

1.5

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

207

1407

0.87

1.13

1.3

46.12

18.59

e6/l

0.38

145

1103

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.54

1.13

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.55

1.11

3.1

2.5

0.17

0.22

u/field

0.17

(3032057) Clostridioides difficile [Presence] in Stool

127

1.45

1.10

1.6

1.7

—

(3016750) Collection duration of Urine

569

0.80

1.09

2.1

510.34

500.13

min

0.53

419

(3024471) HLA-A [Type]

274

0.72

1.09

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

201

1042

1.15

1.09

1.7

1.5

63.38

61.84

0.21

133

696

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

208

1409

0.88

1.09

1.4

513.33

1508.23

e6/l

1.52

156

1169

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

457

1.22

1.07

1.3

1.2

2.17

2.15

mmol/l

0.05

426

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

158

1.39

1.07

1.8

2.8

6.89

8.47

mmol/l

2.14

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.92

1.06

1.2

1.4

—

(3020650) Glucose [Presence] in Urine

154

1.39

1.03

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

610

0.82

1.03

1.2

155.94

198.34

miu/ml

0.40

144

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.52

1.03

1.9

2.1

14.53

16.83

umol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

186

1262

0.87

1.02

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

229

1533

0.89

1.02

1.2

123.81

107.20

titre

0.10

143

(3036489) Thrombin time

420

2286

1.09

1.00

1.8

2.1

21.88

21.93

0.04

377

2024

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

323

0.75

0.99

1.0

0.24

0.30

u/ml

0.17

100

(3007164) IgA [Mass/volume] in Serum or Plasma

1566

8919

1.05

0.98

1.5

1.3

2.73

3.02

g/l

4.62

939

5346

(3045716) Anion gap in Serum or Plasma

402

0.78

0.97

1.9

2.2

10.02

9.75

mmol/l

0.22

393

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

146

1.38

0.97

1.2

312.00

260.49

pmol/l

0.40

109

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

463

1.21

0.97

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

177

0.67

0.96

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

467

0.80

0.95

1.0

0.86

0.97

u/ml

0.10

221

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

162

1.36

0.95

1.1

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

251

1662

0.90

0.94

1.2

1.4

0.24

g/l

0.35

239

1580

(3017569) Oxygen content in Arterial blood

400

1.22

0.93

2.1

2.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

666

0.84

0.92

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.82

0.92

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

395

2156

1.09

0.91

3.4

3.1

4.47

4.43

pmol/l

0.28

351

1924

(3020911) Cortisol [Moles/time] in 24 hour Urine

138

1.38

0.90

1.3

1.7

1133.25

102.72

nmol/24h

0.50

138

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

139

715

1.16

0.89

1.3

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

139

716

1.16

0.88

1.3

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

677

3781

1.07

0.87

4.2

4.0

46.72

48.64

1.21

669

3730

(3010144) Erythrocytes [#/volume] in Synovial fluid

125

860

0.86

0.87

1.3

164492.05

146860.42

e6/l

0.12

610

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1112

6925

0.95

0.87

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

411

2643

0.92

0.86

1.6

102.35

280.29

titre

2.97

104

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.68

0.86

1.5

0.68

0.62

umol/l

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

305

1651

1.10

0.86

1.4

1.5

258.97

269.70

ug/g

0.36

177

1010

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

394

0.80

0.85

1.0

1.1

5.42

6.96

nmol/l

0.23

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

163

852

1.14

0.84

1.1

—

(3044007) Cell count panel - Peritoneal fluid

213

0.72

0.84

1.5

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

171

1.32

0.84

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

151

786

1.14

0.83

1.8

1.3

250.65

413.67

pmol/l

0.65

123

647

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

100

1.43

0.83

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.70

0.83

1.1

1.87

2.20

umol/24h

0.57

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.82

0.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.82

0.0

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

313

0.78

0.82

2.1

2.4

50.98

55.25

umol/l

0.57

262

(21494890) Protein electrophoresis panel - 24 hour Urine

149

776

1.14

0.82

2.1

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.64

0.81

1.0

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

111

765

0.86

0.81

1.2

1.1

7.21

7.64

mmol/l

0.78

645

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.80

0.0

1.2

—

22.04

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

182

1213

0.89

0.80

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

268

1448

1.10

0.80

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.88

0.79

1.0

1.4

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.72

0.79

1.0

1.1

5.93

6.03

mmol/l

0.04

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

183

0.71

0.79

1.2

1.3

0.35

0.31

g/l

1.02

149

(3006576) Bicarbonate [Moles/volume] in Blood

429

0.82

0.79

7.6

6.6

25.53

25.23

mmol/l

0.27

390

(3020891) Body temperature

531

3367

0.93

0.79

4.8

5.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

144

972

0.88

0.79

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

279

1.24

0.79

1.1

1.3

40.88

41.38

g/l

0.08

154

(3018405) Lactate [Moles/volume] in Arterial blood

480

3051

0.93

0.77

4.2

4.6

1.37

1.45

mmol/l

0.73

465

2993

(3020876) Protein [Mass/time] in 24 hour Urine

172

910

1.12

0.76

2.2

2.4

1.13

1.56

g/24h

1.60

467

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

373

2392

0.92

0.76

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

726

4087

1.06

0.76

3.8

3.5

24.92

25.03

mmol/l

0.33

701

3957

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

368

0.81

0.76

1.1

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.12

0.75

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

354

0.81

0.74

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

263

1708

0.91

0.73

1.2

1.4

1.17

g/l

0.04

252

1624

(3026250) Tacrolimus [Mass/volume] in Blood

320

0.80

0.73

26.6

37.0

7.11

7.39

ug/l

0.49

296

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.72

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

535

3378

0.94

0.72

1.7

1.5

22.41

17.22

u/ml

0.21

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.98

0.71

1.8

1.1

1121.48

537.52

nmol/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.73

0.70

1.3

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.52

0.69

1.4

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

183

979

1.11

0.69

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.42

0.68

1.3

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

628

3534

1.06

0.68

1.3

63.39

53.80

au/ml

0.51

209

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

148

985

0.89

0.68

1.5

1.6

107.14

116.10

u/ml

0.55

211

(3020874) Milk IgE Ab [Units/volume] in Serum

170

0.73

0.67

1.1

1.0

0.32

1.04

u/ml

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

230

0.77

0.66

1.2

1.1

98.57

102.73

0.23

182

(3023487) Leukocytes [#/volume] in Peritoneal fluid

263

0.79

0.66

1.4

2.4

1105.38

2549.06

e6/l

0.37

190

(3020961) Endomysium IgA Ab [Titer] in Serum

311

1992

0.93

0.65

1.1

161.88

254.93

titre

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

129

862

0.89

0.64

1.1

1.53

1.56

g/l

0.31

117

777

(3006245) CD3-CD19+ cells/100 cells in Blood

111

1.34

0.64

1.7

2.0

10.15

8.43

0.31

(3023183) Ammonium ion [Moles/volume] in Plasma

286

1836

0.92

0.64

2.1

2.9

30.18

33.83

umol/l

2.29

250

1644

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

192

1254

0.91

0.63

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

215

0.77

0.63

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

0.63

0.0

1.0

—

0.22

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.63

0.0

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.38

0.62

1.2

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.61

0.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.59

0.61

1.3

—

(3011985) Renin [Units/volume] in Plasma

157

841

1.11

0.61

1.8

1.3

84.39

72.09

mu/l

0.24

135

749

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

213

0.78

0.60

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

3865

22578

1.02

0.59

3.2

3.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

165

1080

0.91

0.58

1.7

1.8

255.20

255.31

mu/l

0.00

158

1011

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

381

0.84

0.58

1.5

1.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

111

0.70

0.58

4.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

152

816

1.11

0.57

1.6

1.4

25.45

24.68

0.10

552

(3000060) B lymphocytes [#/volume] in Blood

1.42

0.57

1.6

1.9

17967.14

116.39

e6/l

—

(44813793) Dust mix specific IgE antibody measurement

329

0.83

0.57

1.1

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

849

4845

1.04

0.57

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.34

0.56

1.1

0.72

0.73

umol/24h

0.03

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.62

0.55

2.3

1.4

0.75

1.93

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3630

21208

1.02

0.55

2.9

2.7

6021.32

5269.52

umol/l

0.35

3080

18497

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

353

0.84

0.55

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

353

0.84

0.55

1.1

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.49

0.54

2.1

2.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

352

0.84

0.53

1.1

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

229

0.80

0.53

1.4

2.3

1628.28

4928.82

e6/l

2.38

124

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.58

0.53

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

396

0.85

0.52

1.7

1.3

8.61

6.03

u/l

0.44

341

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

316

1.17

0.52

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.37

0.51

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

406

1.14

0.51

1.8

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

356

0.85

0.50

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

356

0.85

0.50

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

132

1.26

0.50

1.1

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

213

1.20

0.50

1.1

1.0

—

(3024928) Oxygen saturation in Venous blood

318

1777

1.06

0.49

2.7

3.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

355

0.85

0.49

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

124

813

0.91

0.48

1.1

1.2

111.64

109.90

0.24

108

732

(3008116) Ketones [Moles/volume] in Urine by Test strip

149

1.24

0.48

1.2

1.4

—

(36660697) Celiac disease serology panel - Serum

579

3594

0.96

0.48

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

319

1.16

0.48

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

1.27

0.48

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

453

1.13

0.48

1.1

—

(3028433) Virus identified in Specimen by Culture

198

1.20

0.48

1.1

—

(3044927) Protein electrophoresis panel - Urine

154

838

1.09

0.48

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.59

0.47

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.36

0.47

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

128

1.25

0.47

1.6

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

251

1395

1.07

0.47

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

276

1.16

0.46

1.1

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

139

0.77

0.46

1.4

1.8

1.20

1.18

mmol/l

0.63

134

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.40

0.46

1.1

12.85

8.36

u/l

0.40

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.70

0.45

1.0

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

341

2141

0.95

0.45

1.4

1.5

7.27

9.91

iu/ml

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

478

0.88

0.45

2.2

64.39

172.11

ug/min

1.36

131

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

396

0.87

0.45

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

178

0.80

0.45

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

216

1.18

0.45

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1645

10007

0.97

0.45

1.2

1.71

2.12

u/ml

0.59

405

2674

(3009214) Lutropin [Units/volume] in Serum or Plasma

240

1523

0.94

0.45

1.6

1.3

7.58

6.31

u/l

1.40

191

1229

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.29

0.45

1.3

0.98

0.37

mmol/l

0.47

(3019897) Erythrocyte distribution width [Ratio] by Automated count

477

0.88

0.44

2.6

3.5

13.18

13.27

0.43

471

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

687

3933

1.04

0.44

2.4

28.98

22.35

au/ml

0.48

228

(3023419) Bacteria identified in Sputum by Culture

220

1221

1.07

0.44

2.3

—

(3016018) Differential panel - Cerebral spinal fluid

117

632

1.10

0.43

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

156

855

1.09

0.43

1.1

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.43

0.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.43

0.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.43

0.0

1.0

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

104

0.74

0.42

1.2

1.4

75.77

72.75

0.63

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

638

0.90

0.42

1.1

1.2

93.08

97.37

0.84

594

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.56

0.42

1.0

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

103

0.75

0.40

1.2

1.4

369.08

935.38

mu/l

0.81

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

153

1.20

0.40

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

524

2992

1.04

0.39

2.1

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

247

1.16

0.39

2.2

2.4

—

(40762814) Titanium [Mass/volume] in Blood

181

0.82

0.39

2.0

2.4

2.91

3.02

ug/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.37

0.39

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.36

0.39

1.2

1.0

—

(3006270) Folate [Moles/volume] in Blood

113

615

1.09

0.38

1.2

349.00

331.12

nmol/l

0.41

494

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

552

0.90

0.38

2.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

225

0.84

0.38

1.1

1.2

197.11

142.51

nmol/l

0.44

171

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

257

1614

0.95

0.37

1.3

1.2

618.48

584.71

mg/l

0.36

242

1537

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

193

1223

0.94

0.37

1.1

1.2

3.30

8.15

u/ml

—

125

(3036071) Salmonella sp Ab [Titer] in Serum

173

0.82

0.37

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.73

0.36

1.1

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

311

1759

1.05

0.36

2.9

2.8

1.84

1.79

mg/l

0.34

272

1556

(4281824) Cell count and differential, peritoneal fluid

192

0.84

0.36

1.1

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

243

0.86

0.36

1.1

1.0

25.98

10.31

iu/ml

—

(3002079) Sodium [Moles/time] in 24 hour Urine

300

0.87

0.36

1.4

1.2

185.42

190.86

mmol/24h

0.14

300

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.43

0.36

1.0

250.17

221.97

nmol/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.36

0.34

1.1

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

461

0.90

0.34

1.0

1.1

275.44

273.04

mg/l

0.11

420

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.74

0.34

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

509

3131

0.96

0.32

2.4

597.59

609.22

ug/l

0.03

490

2980

(3009015) Lactate [Moles/volume] in Synovial fluid

0.78

0.32

1.2

1.3

5.24

8.12

mmol/l

—

(3028717) Thiamine [Mass/volume] in Blood

0.72

0.32

1.6

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

542

1.09

0.31

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

542

1.09

0.31

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

270

1530

1.05

0.31

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

277

0.88

0.31

3.3

5.9

73.15

71.10

0.18

239

(3046861) Legionella sp Ag [Presence] in Urine

1.33

0.31

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

389

0.90

0.30

1.4

1.3

1.52

1.47

g/l

0.81

389

(3000034) Microalbumin [Mass/volume] in Urine

137

762

1.07

0.30

3.2

3.0

36.71

56.10

mg/l

0.71

103

577

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3924

23086

1.01

0.30

2.2

2.3

242.36

271.01

u/l

1.08

3666

21678

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

226

1410

0.95

0.29

1.3

1.2

3.82

4.00

mmol/l

1.64

210

1331

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

442

1.09

0.29

1.2

1.3

82.00

94.62

titre

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

368

1.10

0.28

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.74

0.28

8.3

9.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

248

1542

0.96

0.28

2.8

2.9

0.82

0.80

nmol/l

0.16

181

1177

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

198

1238

0.95

0.28

1.1

1.2

3.71

7.11

u/ml

1.22

186

(46235355) HIV 1 and 2 tests - Meaningful Use set

1061

6179

1.02

0.27

1.5

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

177

1.14

0.27

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

273

1.11

0.26

1.4

1.6

56.39

99.40

umol/l

1.45

129

(3015076) Soybean IgE Ab [Units/volume] in Serum

141

0.84

0.26

1.2

1.0

0.52

0.36

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.20

0.26

1.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

347

0.91

0.25

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

101

642

0.93

0.25

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

337

1.09

0.25

1.1

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

139

1.15

0.25

12.1

10.8

5.44

5.70

mmol/l

0.17

139

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.73

0.25

1.0

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

303

1.10

0.25

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

228

0.89

0.25

1.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.28

0.24

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

106

1.18

0.24

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.35

0.24

4.4

3.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

321

1.09

0.24

1.1

—

(3020491) Glucose [Moles/volume] in Blood

534

1.07

0.23

1.3

2.0

7.25

7.29

mmol/l

0.04

364

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1569

9457

0.98

0.23

7.6

7.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

189

0.88

0.23

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

368

1.08

0.22

1.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

2.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

263

1507

1.04

0.22

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.26

0.22

1.0

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

134

838

0.95

0.21

1.2

1.3

3.12

4.15

u/ml

0.62

403

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

106

0.84

0.21

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

225

0.90

0.21

1.4

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

262

1504

1.04

0.20

1.2

—

(3024263) Appearance of Synovial fluid

477

0.93

0.20

1.4

1.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.23

0.20

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

162

0.88

0.20

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

136

771

1.05

0.19

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

260

1495

1.03

0.19

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

159

905

1.04

0.19

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

247

1518

0.97

0.19

1.6

1.7

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.15

0.19

1.0

1.1

200.50

234.96

u/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

180

0.89

0.19

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

103

1.15

0.19

1.3

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.21

0.19

1.7

3.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.81

0.19

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

303

1.08

0.18

1.1

1.2

—

(3000285) Sodium [Moles/volume] in Blood

0.85

0.18

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

272

0.92

0.18

1.5

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

333

2033

0.97

0.18

1.1

117.66

106.82

iu/ml

0.21

101

716

(3006922) Hepatitis E virus Ab [Presence] in Serum

390

1.07

0.18

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

145

826

1.04

0.17

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

350

1.07

0.17

1.1

323.47

340.16

mg/l

0.22

315

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.74

0.17

8.8

10.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.71

0.17

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.17

0.17

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

141

0.88

0.17

1.1

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

368

1.07

0.17

1.1

50.98

47.15

mg/l

0.25

320

(3051593) INR in Capillary blood by Coagulation assay

455

1.06

0.16

13.5

9.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

264

0.92

0.16

1.1

1.0

1.09

1.04

u/l

0.35

127

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.76

0.16

1.2

1.1

7113.83

225.26

u/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

159

0.90

0.16

1.3

1.5

11.89

9.70

ug/l

0.87

159

(3001729) Color of Synovial fluid

1.17

0.16

1.3

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

617

0.95

0.16

1.5

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.14

0.15

3.3

3.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.15

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.82

0.15

1.4

—

(4212803) Bone marrow aspirate examination

0.80

0.15

1.3

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

0.78

0.15

1.1

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

152

0.90

0.15

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

195

0.91

0.14

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

195

0.91

0.14

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

195

0.91

0.14

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

195

0.91

0.14

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

158

0.90

0.14

1.5

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

140

862

0.96

0.14

1.2

1.3

6.15

3.39

u/ml

0.63

308

(3021788) Differential panel - Synovial fluid

244

1488

0.97

0.14

1.5

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

106

1.12

0.14

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

353

0.94

0.13

1.5

1.3

3.03

1.21

u/ml

0.51

229

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

299

1817

0.98

0.13

1.7

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

136

836

0.97

0.13

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

431

0.95

0.13

1.3

1.5

14.61

15.18

umol/l

0.27

400

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

224

0.93

0.13

1.5

1.3

39.00

36.78

0.11

146

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

170

1.08

0.12

1.1

—

(3016038) Potassium [Moles/volume] in Urine

408

1.05

0.12

1.1

1.2

35.56

34.21

mmol/l

0.22

348

(3045683) HLA typing for celiac disease panel - Blood or Tissue

205

1.07

0.12

1.0

—

(3023410) Appearance of Cerebral spinal fluid

581

0.96

0.12

1.5

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

141

812

1.03

0.12

1.5

1.6

4.07

16.62

iu/l

0.50

249

(3050794) Legionella sp Ab [Presence] in Serum

1.14

0.12

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

136

1.09

0.11

1.3

1.2

1.65

1.29

mmol/l

1.24

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

119

1.10

0.11

1.1

85.69

80.20

0.30

(3017143) Hepatitis C virus Ab [Presence] in Serum

828

4867

1.01

0.11

1.6

1.7

—

(3022689) Creatine [Moles/volume] in Urine

229

1.06

0.11

1.6

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

102

1.11

0.11

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.87

0.11

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

112

0.90

0.10

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

121

697

1.03

0.10

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

276

1.06

0.10

2.3

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

276

1.06

0.10

2.3

2.4

—

(3044290) Cell count panel - Cerebral spinal fluid

208

1264

0.98

0.10

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

470

0.96

0.10

1.2

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

114

1.09

0.10

1.2

5365.26

125.18

ng/l

0.52

(3034274) Bile acid [Moles/volume] in Serum --fasting

166

1.07

0.10

1.0

1.2

11.23

10.95

umol/l

0.02

120

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.10

0.10

1.4

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.10

0.10

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.15

0.09

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

105

0.91

0.09

1.4

82.75

85.88

—

(3029075) Extractable nuclear Ab panel - Serum

160

0.93

0.09

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

111

0.91

0.09

1.4

1.2

43.38

51.00

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

111

0.91

0.09

1.1

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

191

1159

0.98

0.09

1.1

1.2

—

14.71

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.13

0.09

1.2

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

354

1.04

0.08

2.1

2.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

175

1062

0.98

0.08

1.1

1.2

1.11

7.29

u/ml

—

(3015183) Erythrocyte sedimentation rate

226

1.05

0.08

1.5

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

160

931

1.02

0.08

1.3

287.13

288.55

u/ml

0.02

613

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.85

0.08

2.0

2.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.10

0.07

1.5

1.6

36.67

44.26

umol/l

0.59

(3013139) Helicobacter pylori Ag [Presence] in Stool

576

3456

0.99

0.07

1.2

1.3

—

(4146454) Self-monitoring of blood glucose

179

1044

1.02

0.07

2.6

2.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.85

0.07

1.1

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

186

1086

1.02

0.07

1.4

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.90

0.07

3.1

2.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

327

1.04

0.06

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

109

0.93

0.06

1.1

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

109

0.93

0.06

1.0

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.09

0.06

1.7

1.4

0.65

0.94

ml/s/173m2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

566

0.98

0.06

1.7

1.6

40.00

28.36

u/ml

0.80

129

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.09

0.06

1.1

1.0

—

(40757373) Influenza virus identified in Isolate

157

0.95

0.06

1.9

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.91

0.05

1.3

1.0

0.82

0.38

u/ml

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.11

0.05

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

129

1.06

0.05

1.3

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

102

0.93

0.05

1.1

1.3

74.38

76.35

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

335

1.03

0.05

1.2

7.0

57.45

2333.50

mg/l

1.34

248

(3034426) Prothrombin time (PT)

192

0.96

0.04

1.2

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

140

820

1.01

0.04

1.9

1.8

5.01

4.97

mmol/24h

0.05

117

722

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

515

0.98

0.04

1.0

1.1

3.14

4.01

u/ml

0.24

205

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.91

0.04

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

323

1905

1.01

0.03

1.2

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

233

0.97

0.03

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

532

0.98

0.03

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

154

1.04

0.03

1.7

1.8

118.85

157.82

ng/l

0.91

154

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

173

0.96

0.03

1.2

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

119

1.05

0.03

2.1

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

350

2068

1.01

0.03

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

226

0.97

0.02

1.1

1424.37

1631.00

miu/ml

0.45

226

(3026470) Cobalt [Mass/volume] in Blood

107

628

1.01

0.02

1.8

2.0

4.14

3.28

ug/l

0.34

575

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.95

0.02

2.3

2.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.94

0.02

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

494

2925

1.00

0.02

1.3

1.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.08

0.02

1.1

1.3

1.30

1.33

—

(3025577) Chromium [Mass/volume] in Blood

104

612

1.01

0.01

2.0

2.1

2.46

1.90

ug/l

0.56

507

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

475

0.99

0.01

2.5

2.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

233

1.02

0.01

1.2

1.4

0.12

nmol/l

0.04

194

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

168

1.03

0.01

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

287

1.01

0.01

1.2

81.50

49.65

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

115

1.03

0.00

1.8

1.1

74.00

79.40

0.18

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

311

1.01

0.00

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.94

0.00

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

929

5517

1.00

0.00

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

258

1.01

0.00

1.7

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.96

0.00

1.5

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

165

1.01

0.00

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

168

0.99

0.00

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.99

0.00

1.1

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

270

0.99

0.00

1.1

538.13

731.05

ng/l

0.18

(3002331) Protein [Mass/volume] in Peritoneal fluid

177

1.01

0.00

1.3

1.5

23.64

56.04

g/l

0.50

141

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

144

0.99

0.00

1.1

1.2

217.63

0.82

mg/l

0.48

106

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.96

0.00

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.96

-0.00

1.2

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.85

-0.00

1.2

1.5

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.4

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

1.82

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.02

-0.00

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

-0.00

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.95

-0.00

1.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.91

-0.00

1.1

1.3

276.25

362.37

umol/24h

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_PROSTATE_WIDE – Malignant neoplasm of prostate, including Hilmo

GWS hits: 118

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of prostate, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of prostate, including Hilmo (C3_PROSTATE_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints